,Title,PMID,Authors,Citation,First_Author,Journal/Book,Publication_Year/Date,PMCID,DOI,Keywords,N_Citations,Authors/Affiliations
0,P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis,36864161,"Tylawsky DE, Kiguchi H, Vaynshteyn J, Gerwin J, Shah J, Islam T, Boyer JA, Boué DR, Snuderl M, Greenblatt MB, Shamay Y, Raju GP, Heller DA",Nat Mater. 2023 Mar;22(3):391-399. doi: 10.1038/s41563-023-01481-9,Tylawsky DE,Nat Mater,2023,PMC9981459,10.1038/s41563-023-01481-9,"Medulloblastoma is the most common malignant paediatric brain tumour, with ~30% mediated by Sonic hedgehog signalling Vismodegib-mediated inhibition of the Sonic hedgehog effector Smoothened inhibits tumour growth but causes growth plate fusion at effective doses Here, we report a nanotherapeutic approach targeting endothelial tumour vasculature to enhance blood-brain barrier crossing We use fucoidan-based nanocarriers targeting endothelial P-selectin to induce caveolin-1-dependent transcytosis and thus nanocarrier transport into the brain tumour microenvironment in a selective and active manner, the efficiency of which is increased by radiation treatment In a Sonic hedgehog medulloblastoma animal model, fucoidan-based nanoparticles encapsulating vismodegib exhibit a striking efficacy and marked reduced bone toxicity and drug exposure to healthy brain tissue Overall, these findings demonstrate a potent strategy for targeted intracranial pharmacodelivery that overcomes the restrictive blood-brain barrier to achieve enhanced tumour-selective penetration and has therapeutic implications for diseases within the central nervous system",4,"{'Daniel E Tylawsky': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.', 'Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.'], 'Hiroto Kiguchi': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.', 'Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.'], 'Jake Vaynshteyn': ['Departments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.'], 'Jeffrey Gerwin': ['Departments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.'], 'Janki Shah': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.'], 'Taseen Islam': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.'], 'Jacob A Boyer': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.'], 'Daniel R Boué': [""Departments of Pathology & Laboratory Medicine, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA.""], 'Matija Snuderl': ['Division of Neuropathology, Department of Pathology, NYU Langone Medical Center, New York, NY, USA.'], 'Matthew B Greenblatt': ['Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, & Research Division, Hospital for Special Surgery, New York, NY, USA.'], 'Yosi Shamay': ['Faculty of Biomedical Engineering, Technion Israel Institute of Technology, Haifa, Israel.'], 'G Praveen Raju': ['Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. praveen.raju@mssm.edu.', 'Departments of Neurology and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA. praveen.raju@mssm.edu.', 'Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA. praveen.raju@mssm.edu.'], 'Daniel A Heller': ['Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hellerd@mskcc.org.', 'Department of Pharmacology, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA. hellerd@mskcc.org.']}"
1,Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer,37056561,"Wang Y, Li Y, Zhong J, Li M, Zhou Y, Lin Q, Zong S, Luo W, Wang J, Wang K, Wang J, Xiong L",Theranostics. 2023 Mar 13;13(5):1684-1697. doi: 10.7150/thno.79250,Wang Y,Theranostics,"2023, 03/13/2023",PMC10086203,10.7150/thno.79250,"breast cancer, caveolin 1, exosome, lung metastasis, pre-metastatic niche",2,"{'Yi Wang': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.'], 'Yuqiu Li': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.', 'Queen Mary college, Nanchang University, Nanchang 330006, China.'], 'Junpei Zhong': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.'], 'Miao Li': ['Second Clinical Medical College, Nanchang University, Nanchang 330006, China.'], 'Youjia Zhou': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.'], 'Qing Lin': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.'], 'Siwen Zong': ['Second Clinical Medical College, Nanchang University, Nanchang 330006, China.'], 'Wenting Luo': ['Second Clinical Medical College, Nanchang University, Nanchang 330006, China.'], 'Jiayang Wang': ['First Clinical Medical College, Nanchang University, Nanchang 330006, China.'], 'Keqin Wang': ['First Clinical Medical College, Nanchang University, Nanchang 330006, China.'], 'Jie Wang': ['Key laboratory of functional and clinical translational medicine, Xiamen Medical College, Fujian province university, Xiamen 361023, China.'], 'Lixia Xiong': ['Department of Pathophysiology, Medical College, Nanchang University, 461 Bayi Road, Nanchang 330006, China.', 'Key laboratory of functional and clinical translational medicine, Xiamen Medical College, Fujian province university, Xiamen 361023, China.']}"
2,BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer,36594082,"He X, Chen H, Zhong X, Wang Y, Hu Z, Huang H, Zhao S, Wei P, Shi D, Li D",Int J Biol Sci. 2023 Jan 1;19(1):331-345. doi: 10.7150/ijbs.72538,He X,Int J Biol Sci,"2023, 01/01/2023",PMC9760448,10.7150/ijbs.72538,"BST2, Biomarker, Colorectal cancer (CRC), M2 macrophages",2,"{'Xuefeng He': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Huaijun Chen': ['Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.'], 'Xinyang Zhong': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Yaxian Wang': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Zijuan Hu': ['Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Institute of Pathology, Fudan University, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Huixia Huang': ['Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Institute of Pathology, Fudan University, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Senlin Zhao': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Ping Wei': ['Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Institute of Pathology, Fudan University, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Debing Shi': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.'], 'Dawei Li': ['Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.', 'Department of Oncology, Shanghai Medical College Fudan University, Shanghai, China.']}"
3,Loss of Caveolin-1 Expression in Tumor Cells is Associated with Increased Aggressiveness and Cell Invasion in Oral Squamous Cell Carcinoma,37233885,"Nascimento RB, Paiva KBS, Risteli M, Silva LHS, Rodini CO, Rodrigues MFSD, De Cicco R, Lopez RVM, Salo TA, Nunes FD, Xavier FCA",Head Neck Pathol. 2023 Sep;17(3):618-630. doi: 10.1007/s12105-023-01562-w,Nascimento RB,Head Neck Pathol,2023,,10.1007/s12105-023-01562-w,"Caveolae, Caveolin-1, Epithelial-mesenchymal transition, Oral tongue squamous cell carcinoma, Silencing of the gene, Tumor aggressiveness",0,"{'Rebeca Barros Nascimento': ['Laboratório de Patologia Oral Cirúrgica, Faculdade de Odontologia, Universidade Federal da Bahia, Rua Araújo Pinho, 62, Canela, Salvador, Bahia, 40110-150, Brazil.'], 'Katiúcia Batista Silva Paiva': ['Laboratório de Biologia da Matriz Extracelular e Interação Celular, Departamento de Anatomia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.'], 'Maija Risteli': ['Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland.', 'Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.'], 'Luiz Henrique Santos Silva': ['Laboratório de Biologia da Matriz Extracelular e Interação Celular, Departamento de Anatomia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.'], 'Camila Oliveira Rodini': ['Departamento de Ciências Biológicas, Faculdade de Odontologia de Bauru, Universidade de São Paulo, Bauru, Brazil.'], 'Maria Fernanda Setúbal Destro Rodrigues': ['Programa de Pós-Graduação em Biofotônica Aplicada a Ciências da Saúde, Universidade Nove de Julho, UNINOVE, São Paulo, Brazil.'], 'Rafael De Cicco': ['Departamento de Cirurgia de Cabeça e Pescoço, Instituto de Câncer Doutor Arnaldo Vieira de Carvalho, São Paulo, Brazil.'], 'Rossana Verónica Mendoza Lopez': ['Centro de Pesquisa Translacional em Oncologia, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.'], 'Tuula Anneli Salo': ['Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland.', 'Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.', 'Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland.', 'Department of Pathology, HUSLAB, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.'], 'Fábio Daumas Nunes': ['Laboratório de Patologia Molecular, Faculdade de Odontologia, Universidade de São Paulo, São Paulo, Brazil.'], 'Flávia Caló Aquino Xavier': ['Laboratório de Patologia Oral Cirúrgica, Faculdade de Odontologia, Universidade Federal da Bahia, Rua Araújo Pinho, 62, Canela, Salvador, Bahia, 40110-150, Brazil. fcalo@ufba.br.']}"
4,A narrative review of the role of exosomes and caveolin-1 in liver diseases and cancer,37196562,"Jiang X, Wu S, Hu C",Int Immunopharmacol. 2023 Jul;120:110284. doi: 10.1016/j.intimp.2023.110284,Jiang X,Int Immunopharmacol,2023,,10.1016/j.intimp.2023.110284,"Cancer, Caveolin-1, Exosome, Liver disease, Metastasis and invasion",0,"{'Xiangfu Jiang': ['Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui medical university, Hefei 230032, China; Key Laboratory of anti-inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China.'], 'Shuai Wu': ['Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui medical university, Hefei 230032, China; Key Laboratory of anti-inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China.'], 'Chengmu Hu': ['Anhui Province Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui medical university, Hefei 230032, China; Key Laboratory of anti-inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China. Electronic address: huchengmu@ahmu.edu.cn.']}"
5,Caveolin-1-derived peptide attenuates cigarette smoke-induced airway and alveolar epithelial injury,37642665,"Das DN, Puthusseri B, Gopu V, Krishnan V, Bhagavath AK, Bolla S, Saini Y, Criner GJ, Marchetti N, Tang H, Konduru NV, Fan L, Shetty S",Am J Physiol Lung Cell Mol Physiol. 2023 Aug 29. doi: 10.1152/ajplung.00178.2022,Das DN,Am J Physiol Lung Cell Mol Physiol,"2023, 08/29/2023",,10.1152/ajplung.00178.2022,"caveolin-1 scaffolding domain peptide, chronic obstructive pulmonary disease, tobacco smoke exposure",0,"{'Durgesh Nandini Das': ['Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Bijesh Puthusseri': ['The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Venkadesaperumal Gopu': ['Cellular and Molecular biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Venugopal Krishnan': ['Texas Lung injury Institute, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Ashoka Kumar Bhagavath': ['Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Sudhir Bolla': ['Thoracic Medicine and Surgery, Temple University, Philadelphia, PA, United States.'], 'Yogesh Saini': ['Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, LA, United States.'], 'Gerard J Criner': ['Temple University, Philadelphia, PA, United States.'], 'Nathaniel Marchetti': ['Thoracic Medicine and Surgery, Temple University, Philadelphia, PA, United States.'], 'Hua Tang': ['Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Nagarjun V Konduru': ['Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Liang Fan': ['Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.'], 'Sreerama Shetty': ['Specialty Care Services, The University of Texas Health Science Center at Tyler, Tyler, TX, United States.']}"
6,Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in glioma,36591963,"Xie Y, He L, Zhang Y, Huang H, Yang F, Chao M, Cao H, Wang J, Li Y, Zhang L, Xin L, Xiao B, Shi X, Zhang X, Tang J, Uhrbom L, Dimberg A, Wang L, Zhang L",Neuro Oncol. 2023 Jun 2;25(6):1073-1084. doi: 10.1093/neuonc/noac288,Xie Y,Neuro Oncol,"2023, 06/02/2023",PMC10237416,10.1093/neuonc/noac288,"Wnt signaling, blood-brain barrier, drug delivery, endothelial cell, glioblastoma",0,"{'Yuan Xie': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Liqun He': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.'], 'Yanyu Zhang': [""Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.""], 'Hua Huang': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.'], 'Fan Yang': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.', 'Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neuro-injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Min Chao': [""Department of Neurosurgery, Tangdu Hospital of the Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, China.""], 'Haiyan Cao': [""Department of Neurosurgery, Tangdu Hospital of the Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, China.""], 'Jianhao Wang': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.', 'Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin Neurological Institute, Key Laboratory of Post-Neuro-injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Yaling Li': [""Department of Obstetrics and Gynaecology, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, 710005, China.""], 'Lingxue Zhang': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Lele Xin': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Bing Xiao': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Xinxin Shi': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Xue Zhang': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""], 'Jiefu Tang': ['Trauma Center, First Affiliated Hospital of Hunan University of Medicine, Huaihua, 418000, China.'], 'Lene Uhrbom': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.'], 'Anna Dimberg': ['Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Rudbeck Laboratory, 75185, Uppsala, Sweden.'], 'Liang Wang': [""Department of Neurosurgery, Tangdu Hospital of the Fourth Military Medical University, 569 Xinsi Road, Xi'an, 710038, China.""], 'Lei Zhang': [""China-Sweden International Joint Research Center for Brain Diseases, Key Laboratory of Ministry of Education for Medicinal Plant Resource and Natural Pharmaceutical Chemistry, National Engineering Laboratory for Resource Developing of Endangered Chinese Crude Drugs in Northwest of China, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.""]}"
7,Caveolin-1-Related Intervention for Fibrotic Lung Diseases,36831221,"Shetty S, Idell S",Cells. 2023 Feb 9;12(4):554. doi: 10.3390/cells12040554,Shetty S,Cells,"2023, 02/09/2023",PMC9953971,10.3390/cells12040554,"AECs, CSP7, Caveolin-1, IPF, dry powder inhalational therapy, fLfs, interstitial lung diseases, p53, pulmonary fibrosis",0,"{'Sreerama Shetty': ['Texas Lung Injury Institute, Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.'], 'Steven Idell': ['Texas Lung Injury Institute, Department of Cellular and Molecular Biology, The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.']}"
8,"The intertwining roles of caveolin, oxytocin receptor, and the associated signalling pathways in prostate cancer progression",37217187,Gould ML,Reprod Fertil Dev. 2023 Jun;35(9):493-503. doi: 10.1071/RD22283,Gould ML,Reprod Fertil Dev,2023,,10.1071/RD22283,"Caveolae are invaginations in the plasma membrane of most cell types and are present in the cells of normal prostate tissue Caveolins are a family of highly conserved integral membrane proteins that oligomerise to form caveolae and interact with signalling molecules by providing a scaffold that sequesters signal transduction receptors in close proximity to each other Signal transduction G proteins and G-protein-coupled receptors (GPCR), including oxytocin receptor (OTR), are localised within caveolae Only one OTR has been identified, and yet, this single receptor both inhibits and stimulates cell proliferation As caveolae sequester lipid-modified signalling molecules, these differing effects may be due to a change in location The cavin1 necessary for caveolae formation is lost in prostate cancer progression With the loss of caveolae, the OTR moves out onto the cell membrane influencing the proliferation and survival of prostate cancer cells Caveolin-1 (cav-1) is reportedly overexpressed in prostate cancer cells and is associated with disease progression This review focuses on the position of OTRs within caveolae, and their movement out onto the cell membrane It explores whether movement of the OTR is related to changes in the activation of the associated cell signalling pathways that may increase cell proliferation and analyse whether caveolin and particularly cavin1 might be a target for future therapeutic stratagies",0,"{'M L Gould': ['Department of Anatomy, University of Otago, P.O. Box 913, Dunedin 9054, New Zealand.']}"
9,Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer,37017811,"Godina C, Tryggvadottir H, Bosch A, Borgquist S, Belting M, Isaksson K, Jernström H",Breast Cancer Res Treat. 2023 Jun;199(2):335-347. doi: 10.1007/s10549-023-06919-x,Godina C,Breast Cancer Res Treat,2023,PMC10175335,10.1007/s10549-023-06919-x,"Caveolin-1, Contralateral breast cancer, Genotype, Locoregional breast cancer recurrence",0,"{'Christopher Godina': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden.'], 'Helga Tryggvadottir': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden.', 'Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund and Malmö, Sweden.'], 'Ana Bosch': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden.', 'Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund and Malmö, Sweden.'], 'Signe Borgquist': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden.', 'Department of Oncology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.'], 'Mattias Belting': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden.', 'Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund and Malmö, Sweden.', 'Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.'], 'Karolin Isaksson': ['Division of Surgery, Department of Clinical Sciences in Lund, Lund University and Kristianstad Hospital, Lund and Kristianstad, Sweden.'], 'Helena Jernström': ['Division of Oncology, Department of Clinical Sciences in Lund, Lund University and Skåne University Hospital, Barngatan 4, 221 85, Lund, Sweden. helena.jernstrom@med.lu.se.']}"
10,Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β-catenin signaling and tumor growth,37699867,"Azbazdar Y, Demirci Y, Heger G, Ipekgil D, Karabicici M, Ozhan G",Mol Oncol. 2023 Sep 12. doi: 10.1002/1878-0261.13520,Azbazdar Y,Mol Oncol,"2023, 09/12/2023",,10.1002/1878-0261.13520,"Wnt/β-catenin pathway, ceramide, comparative lipidome profiling, diacylglycerol, hepatocellular carcinoma, plasma membrane",0,"{'Yagmur Azbazdar': ['Izmir Biomedicine and Genome Center (IBG), Dokuz Eylul University Health Campus, Izmir, Turkey.', 'Izmir International Biomedicine and Genome Institute (IBG-Izmir), Dokuz Eylul University, Izmir, Turkey.'], 'Yeliz Demirci': ['Izmir Biomedicine and Genome Center (IBG), Dokuz Eylul University Health Campus, Izmir, Turkey.', 'Izmir International Biomedicine and Genome Institute (IBG-Izmir), Dokuz Eylul University, Izmir, Turkey.'], 'Guillaume Heger': ['École Centrale de Nantes, France.'], 'Dogac Ipekgil': ['Izmir Biomedicine and Genome Center (IBG), Dokuz Eylul University Health Campus, Izmir, Turkey.', 'Izmir International Biomedicine and Genome Institute (IBG-Izmir), Dokuz Eylul University, Izmir, Turkey.'], 'Mustafa Karabicici': ['Izmir Biomedicine and Genome Center (IBG), Dokuz Eylul University Health Campus, Izmir, Turkey.', 'Izmir International Biomedicine and Genome Institute (IBG-Izmir), Dokuz Eylul University, Izmir, Turkey.'], 'Gunes Ozhan': ['Izmir Biomedicine and Genome Center (IBG), Dokuz Eylul University Health Campus, Izmir, Turkey.', 'Izmir International Biomedicine and Genome Institute (IBG-Izmir), Dokuz Eylul University, Izmir, Turkey.']}"
11,Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022,37576808,"Tan Y, Song Q",Front Pharmacol. 2023 Jul 28;14:1237456. doi: 10.3389/fphar.2023.1237456,Tan Y,Front Pharmacol,"2023, 07/28/2023",PMC10416243,10.3389/fphar.2023.1237456,"CiteSpace, R-bibliometrix, VOSviewer, bibliometric analysis, cancer, caveolin, visualization",0,"{'Yaqian Tan': ['Department of Pharmacy, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.'], 'Qi Song': ['Department of Pharmacy, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China.']}"
12,Caveolin-1 protein expression as a prognostic biomarker of gastrointestinal tumours: A systematic review and meta-analysis,37497737,"Kamposioras K, Dinas PC, Barriuoso J, Trachana V, Dimas K",Eur J Clin Invest. 2023 Jul 27:e14065. doi: 10.1111/eci.14065,Kamposioras K,Eur J Clin Invest,"2023, 07/27/2023",,10.1111/eci.14065,"biomarker, caveolin-1, gastrointestinal cancers, meta-analysis, prognosis, survival",0,"{'Konstantinos Kamposioras': ['The Christie NHS Foundation Trust, Manchester, UK.'], 'Petros C Dinas': ['FAME Laboratory, Department of Physical Education and Sport Science, University of Thessaly, Volos, Greece.'], 'Jorge Barriuoso': ['The Christie NHS Foundation Trust, Manchester, UK.', 'Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.'], 'Varvara Trachana': ['Department of Biology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Volos, Greece.'], 'Konstantinos Dimas': ['Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Volos, Greece.']}"
13,CAV1 Impacts the Tumor Immune Microenvironment and Has Potential Value of Predicting Response to Immunotherapy in Esophageal Cancer,36638349,"Zhang R, Wang H, Xiao J, Lu J, Li M, Zhou Y, Sun H, Liu L, Huang T, Zhao Q",DNA Cell Biol. 2023 Jan;42(1):27-42. doi: 10.1089/dna.2022.0025,Zhang R,DNA Cell Biol,2023,,10.1089/dna.2022.0025,"CAV1, TIDE, TME, esophageal cancer, immune cells infiltration",0,"{'Runan Zhang': ['Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.', 'Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.'], 'Haizhou Wang': ['Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.', 'Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.'], 'Jun Xiao': ['Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.', 'Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.'], 'Jie Lu': ['Hubei Aerospace Hospital, Xiaogan, Hubei, China.'], 'Menglin Li': ['Hubei Aerospace Hospital, Xiaogan, Hubei, China.'], 'You Zhou': ['Hubei Aerospace Hospital, Xiaogan, Hubei, China.'], 'He Sun': ['Hubei Aerospace Hospital, Xiaogan, Hubei, China.'], 'Lan Liu': ['Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.', 'Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.'], 'Tizheng Huang': ['Hubei Aerospace Hospital, Xiaogan, Hubei, China.'], 'Qiu Zhao': ['Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.', 'Hubei Clinical Center and Key Lab of Intestinal and Colorectal Diseases, Wuhan, China.']}"
14,"Expression of Cav-1, MCT1, and MCT4 in Ductal Carcinoma In Situ of the Breast and Their Associations With Clinicopathologic Features",36867736,"Kim NI, Park MH, Lee JS",Appl Immunohistochem Mol Morphol. 2023 Apr 1;31(4):204-212. doi: 10.1097/PAI.0000000000001106,Kim NI,Appl Immunohistochem Mol Morphol,"2023, 04/01/2023",,10.1097/PAI.0000000000001106,"Loss of caveolin-1 (Cav-1) and upregulation of monocarboxylate transporters (MCTs, especially MCT1 and MCT4) in respectively tumor-associated stromal cells and malignant epithelial cells of invasive carcinoma have been found to play an important role in the metabolic coupling However, this phenomenon has only been scarcely described in pure ductal carcinoma in situ (DCIS) of the breast mRNA and protein expression levels of Cav-1, MCT1, and MCT4 in nine pairs of DCIS tissues and matched normal tissues were examined by quantitative real-time polymerase chain reaction, RNAscope in situ hybridization, and immunohistochemistry Immunohistochemical staining of Cav-1, MCT1, and MCT4 in 79 DCIS samples was also done using tissue microarray Cav-1 mRNA expression was significantly lower in DCIS tissues than in their corresponding normal tissues In contrast, MCT1 and MCT4 mRNA expression levels were higher in DCIS tissues than in corresponding normal tissues Low stromal Cav-1 expression was significantly associated with high nuclear grade High epithelial MCT4 expression was associated with larger tumor size and human epidermal growth factor 2 positivity At a mean follow-up of 10 years, patients with high epithelial MCT1/high epithelial MCT4 expression showed shorter disease-free survival than those with other expressions No significant association was observed between stromal Cav-1 expression and epithelial MCT 1 or MCT4 expression Changes in Cav-1, MCT1, and MCT4 are associated with carcinogenesis of DCIS A high epithelial MCT1/high epithelial MCT4 expression might be associated with a more aggressive phenotype",0,"{'Nah Ihm Kim': ['Pathology.'], 'Min Ho Park': ['Surgery, Chonnam National University Medical School, Gwangju, South Korea.'], 'Ji Shin Lee': ['Pathology.']}"
15,TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer,37497753,"Roche ME, Ko YH, Domingo-Vidal M, Lin Z, Whitaker-Menezes D, Birbe RC, Tuluc M, Győrffy B, Caro J, Philp NJ, Bartrons R, Martinez-Outschoorn U",Int J Cancer. 2023 Nov 1;153(9):1671-1683. doi: 10.1002/ijc.34660,Roche ME,Int J Cancer,"2023, 11/01/2023",,10.1002/ijc.34660,"TP53 induced glycolysis and apoptosis regulator, c-MYC, glycolysis, metabolic heterogeneity, mitochondrial metabolism, monocarboxylate transporter 4",0,"{'Megan E Roche': ['Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Ying-Hui Ko': ['Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Marina Domingo-Vidal': ['Immunology, Microenvironment & Metastasis Program, Wistar Institute, Philadelphia, Pennsylvania, USA.'], 'Zhao Lin': ['Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Diana Whitaker-Menezes': ['Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Ruth C Birbe': ['Department of Pathology, Cooper University Hospital, Camden, New Jersey, USA.'], 'Madalina Tuluc': ['Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Balázs Győrffy': ['MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.', 'Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary.'], 'Jaime Caro': ['Department of Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Nancy J Philp': ['Department of Pathology, Anatomy and Cell Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.'], 'Ramon Bartrons': ['Department of Physiological Sciences, University of Barcelona, Barcelona, Spain.'], 'Ubaldo Martinez-Outschoorn': ['Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.']}"
16,Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer,37358863,"Kashyap D, Bal A, Irinike S, Khare S, Bhattacharya S, Das A, Singh G",Appl Immunohistochem Mol Morphol. 2023 Sep 1;31(8):533-543. doi: 10.1097/PAI.0000000000001139,Kashyap D,Appl Immunohistochem Mol Morphol,"2023, 09/01/2023",,10.1097/PAI.0000000000001139,"Breast cancer is a heterogenous disease at the molecular level thus, it can be hypothesized that different molecular subtypes differ in their tumor microenvironment (TME) also Understanding the TME heterogeneity may provide new prognostic biomarkers and new targets for cancer therapy For deciphering heterogeneity in the TME, immunohistochemistry for immune markers (CD3, CD4, CD8, CD68, CD163, and programmed death-ligand 1), Cancer-associated fibroblast markers [anti-fibroblast activating protein α (FAP-α), platelet-derived growth factor receptor α (PDGFR-α), S100A4, Neuron-glial antigen 2, and Caveolin-1], and angiogenesis (CD31) was performed on tissue microarrays of different molecular subtypes of breast cancer High CD3 + T cells were noted in the Luminal B subtype ( P =0002) of which the majority were CD8 + cytotoxic T cells Programmed death-ligand 1 expression in immune cells was highest in the human epidermal growth factor receptor 2 (Her-2)-positive and Luminal B subtypes compared with the triple-negative breast cancer (TNBC) subtype ( P =0003) Her-2 subtype is rich in M2 tumor-associated macrophages ( P =0000) compared with TNBC and Luminal B subtypes M2 immune microenvironment correlated with high tumor grade and high Ki-67 Her-2 and TNBC subtypes are rich in extracellular matrix remodeling (FAP-α, P =0003), angiogenesis-promoting (PDGFR-α, P =0000) and invasion markers (Neuron-glial antigen 2, P =0000, S100A4, P =007) compared with Luminal subtypes Mean Microvessel density showed an increasing trend: Luminal A>Luminal B>Her-2 positive>TNBC, however, this difference was not statistically significant The cancer-associated fibroblasts (FAP-α, PDGFR-α, and Neuron-glial antigen 2) showed a positive correlation with lymph node metastasis in specific subtypes Immune cells, tumor-associated macrophage, and cancer-associated fibroblast-related s tromal markers showed higher expression in Luminal B, Her-2 positive, and TNBC respectively This differential expression of different components of TME indicates heterogeneity of the TME across molecular subtypes of breast cancer",0,"{'Dharambir Kashyap': ['Departments of Histopathology.'], 'Amanjit Bal': ['Departments of Histopathology.'], 'Santosh Irinike': ['General Surgery.'], 'Siddhant Khare': ['General Surgery.'], 'Shalmoli Bhattacharya': ['Biophysics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.'], 'Ashim Das': ['Departments of Histopathology.'], 'Gurpreet Singh': ['General Surgery.']}"
17,The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer,37233761,"Zmarzły N, Januszyk S, Mieszczański P, Czarniecka J, Bednarska-Czerwińska A, Boroń D, Oplawski M, Grabarek BO",J Cancer Res Clin Oncol. 2023 Sep;149(12):9679-9689. doi: 10.1007/s00432-023-04863-3,Zmarzły N,J Cancer Res Clin Oncol,2023,PMC10423110,10.1007/s00432-023-04863-3,"Endometrial cancer, Expression profile, TNF signaling, TNF-α, miRNA",0,"{'Nikola Zmarzły': ['Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland. nikola.zmarzly@gmail.com.', 'Department of Gynecology and Obstetrics, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland. nikola.zmarzly@gmail.com.'], 'Szymon Januszyk': ['ICZ Healthcare Hospital in Zywiec, 34-300, Zywiec, Poland.'], 'Paweł Mieszczański': ['Hospital of Ministry of Interior and Administration, 40-052, Katowice, Poland.'], 'Justyna Czarniecka': ['Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.'], 'Anna Bednarska-Czerwińska': ['Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.', 'Gyncentrum, Laboratory of Molecular Biology and Virology, 40-851, Katowice, Poland.', 'American Medical Clinic, 40-600, Katowice, Poland.'], 'Dariusz Boroń': ['Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.', 'Department of Gynecology and Obstetrics, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.', 'Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826, Kraków, Poland.', 'Department of Gynecology and Obstetrics, TOMMED Specjalisci od Zdrowia, 40-662, Katowice, Poland.'], 'Marcin Oplawski': ['Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826, Kraków, Poland.', 'Department of Gynecology and Obstetrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Cracow, 30-705, Cracow, Poland.'], 'Beniamin Oskar Grabarek': ['Department of Histology, Cytophysiology and Embryology, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.', 'Department of Gynecology and Obstetrics, Faculty of Medicine in Zabrze, Academy of Silesia in Katowice, 41-800, Zabrze, Poland.', 'Gyncentrum, Laboratory of Molecular Biology and Virology, 40-851, Katowice, Poland.', 'Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826, Kraków, Poland.', 'Department of Gynecology and Obstetrics, TOMMED Specjalisci od Zdrowia, 40-662, Katowice, Poland.']}"
18,Opposite changes in the expression of clathrin and caveolin-1 in normal and cancerous human prostate tissue: putative clathrin-mediated recycling of EGFR,36869937,"Xie B, Zuhair H, Henrique R, Millar M, Robson T, Thrasivoulou C, Dickens K, Pendjiky J, Muneer A, Patel H, Ahmed A",Histochem Cell Biol. 2023 Jun;159(6):489-500. doi: 10.1007/s00418-023-02183-8,Xie B,Histochem Cell Biol,2023,PMC10247851,10.1007/s00418-023-02183-8,"Cancer, Caveolin, Clathrin, EGFR, Endocytosis, Prostate",0,"{'Boyu Xie': [""Centre for Stem Cells and Regenerative Medicine, King's College London, London, UK.""], 'Hawra Zuhair': [""Centre for Stem Cells and Regenerative Medicine, King's College London, London, UK.""], 'Rui Henrique': ['Department of Pathology and Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto and Department of Pathology and Molecular Immunology, Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal.'], 'Michael Millar': [""Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.""], 'Timothy Robson': ['Research Department of Cell and Developmental Biology, The Centre for Cell and Molecular Dynamics, Rockefeller Building, University College London, London, UK.'], 'Christopher Thrasivoulou': ['Research Department of Cell and Developmental Biology, The Centre for Cell and Molecular Dynamics, Rockefeller Building, University College London, London, UK.'], 'Kerry Dickens': [""Centre for Stem Cells and Regenerative Medicine, King's College London, London, UK.""], 'Jane Pendjiky': ['Research Department of Cell and Developmental Biology, The Centre for Cell and Molecular Dynamics, Rockefeller Building, University College London, London, UK.'], 'Asif Muneer': ['Division of Surgery, University College Hospital, London, UK.'], 'Hiten Patel': ['Department of Urology, University Hospital of North Norway, 9038, Tromsö, Norway.'], 'Aamir Ahmed': [""Centre for Stem Cells and Regenerative Medicine, King's College London, London, UK. aamir.ahmed@ucl.ac.uk."", 'Research Department of Cell and Developmental Biology, The Centre for Cell and Molecular Dynamics, Rockefeller Building, University College London, London, UK. aamir.ahmed@ucl.ac.uk.']}"
19,A proteomic signature and potential pharmacological opportunities in the adaptive resistance to MEK and PI3K kinase inhibition in pancreatic cancer cells,37140101,"Aguilar-Valdés A, González-Vela F, Sánchez-Vidal H, Martínez-Aguilar J",Proteomics. 2023 Aug;23(16):e2300041. doi: 10.1002/pmic.202300041,Aguilar-Valdés A,Proteomics,2023,,10.1002/pmic.202300041,"MEK and PI3K, kinase inhibition, pancreatic cancer, proteomics, resistance",0,"{'Alain Aguilar-Valdés': ['Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México, Mexico City, Mexico.', 'Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.'], 'Francisco González-Vela': ['Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México, Mexico City, Mexico.', 'Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Mexico City, Mexico.'], 'Hilda Sánchez-Vidal': ['Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.'], 'Juan Martínez-Aguilar': ['Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México, Mexico City, Mexico.']}"
20,Plant extract from Caesalpinia spinosa inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model,36923867,"Jiménez MC, Prieto K, Lasso P, Gutiérrez M, Rodriguez-Pardo V, Fiorentino S, Barreto A",Heliyon. 2023 Mar 2;9(3):e14148. doi: 10.1016/j.heliyon.2023.e14148,Jiménez MC,Heliyon,"2023, 03/02/2023",PMC10009686,10.1016/j.heliyon.2023.e14148,"Interactions in the tumor microenvironment (TME) between tumor cells and stromal cells such as cancer-associated fibroblasts (CAF) favor increased survival, progression, and transformation of cancer cells by activating mechanisms of invasion and metastasis The design of new therapies to modulate or eliminate the CAF phenotype or functionality has been the subject of recent research including natural product-based therapies We have previously described the generation of a standardized extract rich in polyphenols obtained from the Caesalpinia spinosa plant (P2Et), which present antitumor activities in breast cancer and melanoma models through activities that modulate the metabolism of tumor cells or induce the development of the immune response In this work, a model of CAF generation was initially developed from the exposure of 3T3 fibroblasts to the cytokine TGFβ1 CAF-like cells generated in this way exhibited changes in the expression of Caveolin-1 and α-SMA, and alterations in glucose metabolism and redox status, typical of CAFs isolated from tumor tissues Then, P2Et was shown to counteract in vitro-induced CAF-like cell generation, preventing caveolin-1 loss and attenuating changes in glucose uptake and redox profile This protective effect of P2Et translates into a decrease in the functional ability of CAFs to support colony formation and migration of 4T1 murine breast cancer tumor cells In addition to the functional interference, the P2Et extract also decreased the expression of genes associated with the epithelial-mesenchymal transition (EMT) and functional activities related to the modulation of the cancer stem cells (CSC) population This work is an in vitro approach to evaluate natural extracts' effect on the interaction between CAF and tumor cells in the tumor microenvironment, thus, these results open the chance to design a more profound and mechanistic analysis to explore the molecular mechanisms of P2Et multimolecular activity and extent this analysis to an in vivo perspective In summary, we present here a standardized polymolecular natural extract that has the potential to act in the TME by interfering with CAF generation and functionality",1,"{'Maria Camila Jiménez': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Karol Prieto': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Paola Lasso': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Melisa Gutiérrez': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Viviana Rodriguez-Pardo': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Susana Fiorentino': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.'], 'Alfonso Barreto': ['Grupo de Inmunobiología y Biología Celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Colombia.']}"
21,LY6K depletion modulates TGF-β and EGF signaling,37076981,"Park S, Park D, Han S, Chung GE, Soh S, Ka HI, Joo HJ, Yang Y",Cancer Med. 2023 Jun;12(11):12593-12607. doi: 10.1002/cam4.5940,Park S,Cancer Med,2023,PMC10278532,10.1002/cam4.5940,"EGF, LY6K, TGF-β, cervical cancer, endocytosis",0,"{'Sujeong Park': [""Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Doyeon Park': ['Novotech, Seoul, Republic of Korea.'], 'Sora Han': [""Research Institute of Women's Health, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Ga Eun Chung': [""Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Sujung Soh': [""Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Hye In Ka': [""Research Institute of Women's Health, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Hyun Jeong Joo': [""Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.""], 'Young Yang': [""Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.""]}"
22,"Cholesterol depletion affects caveolin-1 expression, migration and invasion of oral tongue squamous cell carcinoma cell lines",36989864,"Nascimento RB, Risteli M, Paiva KBS, Juurikka K, Rodrigues MFSD, Salo TA, Xavier FCA",Arch Oral Biol. 2023 Jun;150:105675. doi: 10.1016/j.archoralbio.2023.105675,Nascimento RB,Arch Oral Biol,2023,,10.1016/j.archoralbio.2023.105675,"Caveolin-1 (CAV-1), Cholesterol depletion, E-cadherin (ECAD), Epithelial-mesenchymal transition (EMT), Methyl-β-cyclodextrin (MβCD), Tongue squamous cell carcinoma (OTSCC)",0,"{'Rebeca Barros Nascimento': ['Laboratory of Oral Surgical Pathology, School of Dentistry, Federal University of Bahia, Salvador, Brazil.'], 'Maija Risteli': ['Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.'], 'Katiúcia Batista Silva Paiva': ['Laboratory of Extracellular Matrix Biology and Cellular Interaction, Department of Anatomy, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.'], 'Krista Juurikka': ['Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland; Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.'], 'Maria Fernanda Setúbal Destro Rodrigues': ['Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.'], 'Tuula Anneli Salo': ['Cancer and Translational Medicine Research Unit, Faculty of Medicine, University of Oulu, Oulu, Finland; Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki, Finland; HUSLAB, Department of Pathology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland.'], 'Flávia Caló Aquino Xavier': ['Laboratory of Oral Surgical Pathology, School of Dentistry, Federal University of Bahia, Salvador, Brazil. Electronic address: fcalo@ufba.br.']}"
23,Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma,37554274,"Lin Z, Jiang C, Wang P, Chen Q, Wang B, Fu X, Liang Y, Zhang D, Zeng Y, Liu X",Theranostics. 2023 Jul 16;13(12):4166-4181. doi: 10.7150/thno.85843,Lin Z,Theranostics,"2023, 07/16/2023",PMC10405843,10.7150/thno.85843,"T cell immunoglobulin and mucin domain 3, Virus-like silicon nanoparticles, caveolin, immunotherapy, neoantigen",0,"{'Zhiwen Lin': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', ""Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, People's Republic of China.""], 'Chenwei Jiang': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', ""Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, People's Republic of China.""], 'Peiyuan Wang': ['CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China.'], 'Qingjing Chen': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.'], 'Bing Wang': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.'], 'Xinyue Fu': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.'], 'Yuzhi Liang': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', 'Fujian Agriculture and Forestry University, Fuzhou 350002, P. R. China.'], 'Da Zhang': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', 'Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, P. R. China.'], 'Yongyi Zeng': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', ""Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, People's Republic of China.""], 'Xiaolong Liu': ['The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China.', 'CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China.', 'Mengchao Med-X Center, Fuzhou University, Fuzhou 350116, P. R. China.']}"
24,Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines,36986886,"Smaldone G, Rosa E, Gallo E, Diaferia C, Morelli G, Stornaiuolo M, Accardo A",Pharmaceutics. 2023 Mar 22;15(3):1026. doi: 10.3390/pharmaceutics15031026,Smaldone G,Pharmaceutics,"2023, 03/22/2023",PMC10051563,10.3390/pharmaceutics15031026,"Fmoc-FF peptide, breast cancer cell line, caveolin, diagnostic agents, endocytosis, nanogel",0,"{'Giovanni Smaldone': ['IRCCS Synlab SDN, Via Gianturco 113, 80143 Naples, Italy.'], 'Elisabetta Rosa': ['Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples ""Federico II"", 80131 Naples, Italy.'], 'Enrico Gallo': ['IRCCS Synlab SDN, Via Gianturco 113, 80143 Naples, Italy.'], 'Carlo Diaferia': ['Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples ""Federico II"", 80131 Naples, Italy.'], 'Giancarlo Morelli': ['Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples ""Federico II"", 80131 Naples, Italy.'], 'Mariano Stornaiuolo': ['Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples ""Federico II"", 80131 Naples, Italy.'], 'Antonella Accardo': ['Department of Pharmacy and Research Centre on Bioactive Peptides (CIRPeB), University of Naples ""Federico II"", 80131 Naples, Italy.']}"
25,Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance,37642765,"Liu Y, Chen Y, Wang F, Lin J, Tan X, Chen C, Wu LL, Zhang X, Wang Y, Shi Y, Yan X, Zhao K",Discov Oncol. 2023 Aug 29;14(1):161. doi: 10.1007/s12672-023-00765-5,Liu Y,Discov Oncol,"2023, 08/29/2023",PMC10465474,10.1007/s12672-023-00765-5,"CAV1, DNA methylation, Drug resistance, Glioma, Immunotherapy",0,"{""Yu'e Liu"": ['Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.'], 'Yi Chen': ['The China-US (Henan) Hormel Cancer Institute, Zhengzhou, 450000, China.'], 'Fei Wang': ['Shanghai Pudong Hospital, Pudong Medical Center, Fudan University, Shanghai, 201399, China.'], 'Jianghua Lin': ['Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.'], 'Xiao Tan': [""Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China.""], 'Chao Chen': ['Department of Neurosurgery, Changhai Hospital, No. 168 Changhai Road, Shanghai, 200433, China.'], 'Lei-Lei Wu': ['Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.'], 'Xiaoling Zhang': ['National Joint Engineering Laboratory for Human Disease Animal Models, First Affiliated Hospital of Jilin University, Changchun, China.', 'Key Laboratory of Organ Regeneration and Transplantation, First Hospital of Jilin University, Changchun, China.'], 'Yi Wang': [""Department of Critical Care Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.""], 'Yufeng Shi': [""Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, 200092, China."", 'Clinical Center for Brain and Spinal Cord Research, Tongji University, Shanghai, 200092, China.'], 'Xiaoli Yan': ['Laboratory of Immunology and Pathogen Biology, School of Medicine, Tongji University, Shanghai, 200092, China. yanxl72@tongji.edu.cn.'], 'Kaijun Zhao': ['Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China. zkjwcfzwh@163.com.']}"
26,Peritumoral adipose tissue promotes lipolysis and white adipocytes browning by paracrine action,37181035,"Pagnotta P, Gantov M, Fletcher S, Lombardi A, Crosbie ML, Santiso N, Ursino A, Frascarolli C, Amato A, Dreszman R, Calvo JC, Toneatto J",Front Endocrinol (Lausanne). 2023 Apr 26;14:1144016. doi: 10.3389/fendo.2023.1144016,Pagnotta P,Front Endocrinol (Lausanne),"2023, 04/26/2023",PMC10170974,10.3389/fendo.2023.1144016,"browning, human breast adipose tissue, lipolysis, paracrine action, tumor microenvironment",0,"{'Priscila Pagnotta': ['Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina.', 'Department of Biological Chemistry, Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina.'], 'Mariana Gantov': ['Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina.'], 'Sabrina Fletcher': ['Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina.'], 'Antonella Lombardi': ['Institute of Neurosciences (INEU) FLENI-CONICET, Buenos Aires, Argentina.'], 'María Lujan Crosbie': ['Breast Surgery Section, Churruca-Visca Police Medical Centre, Buenos Aires, Argentina.'], 'Natalia Santiso': ['Breast Surgery Section, Churruca-Visca Police Medical Centre, Buenos Aires, Argentina.'], 'Anabela Ursino': ['Breast Surgery Section, Churruca-Visca Police Medical Centre, Buenos Aires, Argentina.'], 'Celeste Frascarolli': ['Breast Surgery Section, Churruca-Visca Police Medical Centre, Buenos Aires, Argentina.'], 'Alicia Amato': ['Breast Surgery Section, Churruca-Visca Police Medical Centre, Buenos Aires, Argentina.'], 'Rubén Dreszman': ['Microsurgery Clinic, Buenos Aires, Argentina.'], 'Juan Carlos Calvo': ['Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina.', 'Department of Biological Chemistry, Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina.'], 'Judith Toneatto': ['Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina.']}"
27,Polymer/Nanoceria Hybrid Polyplexes for Gene and Antioxidant Delivery,37493016,"Mott L, Hancock M, Grulke EA, Pack DW",ACS Appl Bio Mater. 2023 Aug 21;6(8):3166-3175. doi: 10.1021/acsabm.3c00295,Mott L,ACS Appl Bio Mater,"2023, 08/21/2023",,10.1021/acsabm.3c00295,"antioxidant, gene delivery, hybrid polyplex, nanoceria, polyethylenimine",0,"{'Landon Mott': ['Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.'], 'Matthew Hancock': ['Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.'], 'Eric A Grulke': ['Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.'], 'Daniel W Pack': ['Department of Chemical and Materials Engineering, University of Kentucky, Lexington, Kentucky 40506, United States.', 'Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40536, United States.']}"
28,Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes,36325647,"Mardhekar S, Subramani B, Samudra P, Srikanth P, Mahida V, Ravindra Bhoge P, Toraskar S, Abraham NM, Kikkeri R",Chemistry. 2023 Feb 1;29(7):e202202622. doi: 10.1002/chem.202202622,Mardhekar S,Chemistry,"2023, 02/01/2023",,10.1002/chem.202202622,"CD44 receptor, chondrotin sulfate, gold nanoparticles, heparan sulfate, neural cell lines",0,"{'Sandhya Mardhekar': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Balamurugan Subramani': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Prasanna Samudra': ['Laboratory of Neural Circuits and Behaviour (LNCB) Department of Biology, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Priyadharshini Srikanth': ['Laboratory of Neural Circuits and Behaviour (LNCB) Department of Biology, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Virendrasinh Mahida': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Preeti Ravindra Bhoge': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Suraj Toraskar': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Nixon M Abraham': ['Laboratory of Neural Circuits and Behaviour (LNCB) Department of Biology, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.'], 'Raghavendra Kikkeri': ['Department of Chemistry, Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune, 411008, India.']}"
29,Investigation of the impact of Globo-H expression on the progression of gastric cancer,37560002,"Hsu HT, Kuo TM, Wei CY, Huang JY, Liu TW, Hsing MT, Lai MT, Chen CT",Am J Cancer Res. 2023 Jul 15;13(7):2969-2983,Hsu HT,Am J Cancer Res,"2023, 07/15/2023",PMC10408484,,"Globo-H, HER2, caveolin-1, gastric cancer, immunotherapy, micro-western array",0,"{'Hui-Ting Hsu': ['Department of Pathology, Changhua Christian Hospital Changhua, Taiwan.', 'Institute of Medicine, Chung Shan Medical University Taichung, Taiwan.', 'School of Medicine, Chung Shan Medical University Taichung, Taiwan.', 'Department of Pathology, China Medical University Hospital Taichung, Taiwan.'], 'Tzer-Min Kuo': ['OBI Pharma, Inc. Taipei, Taiwan.'], 'Cheng-Yen Wei': ['OBI Pharma, Inc. Taipei, Taiwan.'], 'Jye-Yu Huang': ['OBI Pharma, Inc. Taipei, Taiwan.'], 'Ting-Wei Liu': ['OBI Pharma, Inc. Taipei, Taiwan.'], 'Ming-Tai Hsing': ['Department of Neurosurgery, Changhua Christian Hospital Changhua, Taiwan.'], 'Ming-Tain Lai': ['OBI Pharma, Inc. Taipei, Taiwan.'], 'Chun-Te Chen': ['OBI Pharma, Inc. Taipei, Taiwan.']}"
30,ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC,37528424,"Zhao Y, Yu J, Huang A, Yang Q, Li G, Yang Y, Chen Y",Cancer Cell Int. 2023 Aug 1;23(1):152. doi: 10.1186/s12935-023-03003-8,Zhao Y,Cancer Cell Int,"2023, 08/01/2023",PMC10394868,10.1186/s12935-023-03003-8,"Caveolae SPARC, Endocytosis effect, ROS, Vasculature normalization",0,"{'Ye Zhao': ['Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.', 'Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.'], 'Jing Yu': ['Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.'], 'Ai Huang': ['Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.', 'Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.'], 'Qin Yang': ['Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.', 'Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.'], 'Guiling Li': ['Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China.', 'Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.'], 'Yong Yang': ['Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, 350001, China. dr_yangyong1983@163.com.'], 'Yeshan Chen': ['Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China. chenyeshan2014@163.com.', 'Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. chenyeshan2014@163.com.']}"
31,EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry,36625722,"Luan H, Bielecki TA, Mohapatra BC, Islam N, Mushtaq I, Bhat AM, Mirza S, Chakraborty S, Raza M, Storck MD, Toss MS, Meza JL, Thoreson WB, Coulter DW, Rakha EA, Band V, Band H",Elife. 2023 Jan 10;12:e81288. doi: 10.7554/eLife.81288,Luan H,Elife,"2023, 01/10/2023",PMC9988264,10.7554/eLife.81288,"EHD2, Orai1, SOCE, STIM1, cancer biology, caveolae, caveolin-1, caveolin-2, cell migration, human, invasiveness, metastasis, triple negative breast cancer, tumorigenesis",1,"{'Haitao Luan': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.'], 'Timothy A Bielecki': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.'], 'Bhopal C Mohapatra': ['Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.', 'Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States.'], 'Namista Islam': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.', 'Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Insha Mushtaq': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.', 'Department of Pathology & Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Aaqib M Bhat': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.', 'Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Sameer Mirza': ['Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Sukanya Chakraborty': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.', 'Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Mohsin Raza': ['Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.'], 'Matthew D Storck': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.'], 'Michael S Toss': ['Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, United Kingdom.'], 'Jane L Meza': ['Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States.', 'Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, United States.'], 'Wallace B Thoreson': ['Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, United States.'], 'Donald W Coulter': ['Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States.', 'Department of Pediatrics, University of Nebraska Medical Center, Omaha, United States.'], 'Emad A Rakha': ['Department of Histopathology, Nottingham University Hospital NHS Trust, City Hospital Campus, Nottingham, United Kingdom.'], 'Vimla Band': ['Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.', 'Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States.'], 'Hamid Band': ['Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, United States.', 'Department of Genetics, Cell Biology and Anatomy, College of Medicine, University of Nebraska Medical Center, Omaha, United States.', 'Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, United States.', 'Department of Pathology & Microbiology, College of Medicine, University of Nebraska Medical Center, Omaha, United States.']}"
32,Caveolin-1-ACE2 axis modulates xenobiotic metabolism-linked chemoresistance in ovarian clear cell carcinoma,35622184,"Nagappan A, Kim KH, Moon Y",Cell Biol Toxicol. 2023 Aug;39(4):1181-1201. doi: 10.1007/s10565-022-09733-1,Nagappan A,Cell Biol Toxicol,2023,PMC9136213,10.1007/s10565-022-09733-1,"Angiotensin-converting enzyme 2, Aryl hydrocarbon receptor, Caveolin-1, Chemotherapy, Ovarian clear cell carcinoma, Xenobiotic metabolism",1,"{'Arulkumar Nagappan': ['Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Pusan National University, Yangsan, 50612, Korea.'], 'Ki-Hyung Kim': ['Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Pusan National University, Yangsan, 50612, Korea.', 'Department of Obstetrics and Gynecology, College of Medicine, Pusan National University, Busan, Korea.', 'Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.'], 'Yuseok Moon': ['Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Pusan National University, Yangsan, 50612, Korea. moon@pnu.edu.', 'Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. moon@pnu.edu.', 'Graduate Program of Genomic Data Sciences, Pusan National University, Yangsan, 50612, Korea. moon@pnu.edu.']}"
33,Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial,37432976,"Williams TM, Schneeweiss A, Jackisch C, Shen C, Weber KE, Fasching PA, Denkert C, Furlanetto J, Heinmöller E, Schmatloch S, Karn T, Szeto CW, van Mackelenbergh MT, Nekljudova V, Stickeler E, Soon-Shiong P, Schem C, Mairinger T, Müller V, Marme F, Untch M, Loibl S",Clin Cancer Res. 2023 Sep 1;29(17):3384-3394. doi: 10.1158/1078-0432.CCR-23-0362,Williams TM,Clin Cancer Res,"2023, 09/01/2023",,10.1158/1078-0432.CCR-23-0362,"Our findings indicate high CAV1/2 expression is associated with worse DFS and OS in paclitaxel-treated patients Conversely, in nab-paclitaxel-treated patients, high CAV1/2 expression is associated with increased pCR and no significant detriment to DFS or OS compared with low CAV1/2 expression",1,"{'Terence M Williams': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.'], 'Andreas Schneeweiss': ['Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.'], 'Christian Jackisch': ['Sana Klinikum Offenbach, Offenbach, Germany.'], 'Changxian Shen': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.'], 'Karsten E Weber': ['German Breast Group, Neu-Isenburg, Germany.'], 'Peter A Fasching': ['Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.'], 'Carsten Denkert': ['Institut für Pathologie Philipps-Universität Marburg, Marburg, Germany.'], 'Jenny Furlanetto': ['German Breast Group, Neu-Isenburg, Germany.'], 'Ernst Heinmöller': ['Pathologie Nordhessen, Kassel, Germany.'], 'Sabine Schmatloch': ['Elisabeth-Krankenhaus Kassel, Germany.'], 'Thomas Karn': ['Department of Gynecology and Obstetrics, Goethe University Frankfurt, Frankfurt, Germany.'], 'Christopher W Szeto': ['NantOmics, LLC, Culver City, California.'], 'Marion T van Mackelenbergh': ['Universitätsklinikum Schleswig-Holstein, Kiel, Germany.'], 'Valentina Nekljudova': ['German Breast Group, Neu-Isenburg, Germany.'], 'Elmar Stickeler': ['Uniklinik RWTH Achen, Aachen, Germany.'], 'Patrick Soon-Shiong': ['NantOmics, LLC, Culver City, California.'], 'Christian Schem': ['Mammazentrum Hamburg, Hamburg, Germany.'], 'Thomas Mairinger': ['HELIOS Klinikum Berlin Buch, Berlin, Germany.'], 'Volkmar Müller': ['Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.'], 'Frederik Marme': ['Universitätsfrauenklinik Mannheim, Mannheim, Germany.'], 'Michael Untch': ['HELIOS Klinikum Berlin Buch, Berlin, Germany.'], 'Sibylle Loibl': ['German Breast Group, Neu-Isenburg, Germany.', 'Centre for Haematology and Oncology, Bethanien Frankfurt/M, Germany.']}"
34,"BIN1, Myotubularin, and Dynamin-2 Coordinate T-Tubule Growth in Cardiomyocytes",37139790,"Perdreau-Dahl H, Lipsett DB, Frisk M, Kermani F, Carlson CR, Brech A, Shen X, Bergan-Dahl A, Hou Y, Tuomainen T, Tavi P, Jones PP, Lunde M, Wasserstrom JA, Laporte J, Ullrich ND, Christensen G, Morth JP, Louch WE",Circ Res. 2023 May 26;132(11):e188-e205. doi: 10.1161/CIRCRESAHA.122.321732,Perdreau-Dahl H,Circ Res,"2023, 05/26/2023",,10.1161/CIRCRESAHA.122.321732,"BIN1, cardiomyocyte, dynamin II, myotubularin, t-tubule",0,"{'Harmonie Perdreau-Dahl': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).', 'Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership University of Oslo, Norway (H.P.-D., J.P.M.).', ""Institut MitoVasc, CNRS UMR 6015, INSERM U1083, Université d'Angers, France (H.P.-D.).""], 'David B Lipsett': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'Michael Frisk': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'Fatemeh Kermani': ['Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany (F.K., N.D.U.).'], 'Cathrine R Carlson': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).'], 'Andreas Brech': ['Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Norway (A.B.).'], 'Xin Shen': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'Anna Bergan-Dahl': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'Yufeng Hou': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'Tomi Tuomainen': ['A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland (T.T., P.T.).'], 'Pasi Tavi': ['A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland (T.T., P.T.).'], 'Peter P Jones': ['Department of Physiology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand (P.P.J.).'], 'Marianne Lunde': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'J Andrew Wasserstrom': ['Northwestern University Feinberg School of Medicine, Chicago, IL (J.A.W.).'], 'Jocelyn Laporte': ['Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM U1258, CNRS UMR7104, Strasbourg University, Illkirch, France (J.L.).'], 'Nina D Ullrich': ['Division of Cardiovascular Physiology, Institute of Physiology and Pathophysiology, Heidelberg University, Germany (F.K., N.D.U.).', 'German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Germany (N.D.U.).'], 'Geir Christensen': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).'], 'J Preben Morth': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership University of Oslo, Norway (H.P.-D., J.P.M.).', 'Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark (J.P.M.).'], 'William E Louch': ['Institute for Experimental Medical Research (IEMR), Oslo University Hospital and University of Oslo, Norway (H.P.-D., D.B.L., M.F., C.R.C., X.S., A.B.-D., Y.H., M.L., G.C., J.P.M., W.E.L.).', 'KG Jebsen Center for Cardiac Research, University of Oslo, Norway (H.P.-D., D.B.L., M.F., X.S., A.B.-D., Y.H., M.L., G.C., W.E.L.).']}"
35,Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells,37399497,"Ventura E, Belfiore A, Iozzo RV, Giordano A, Morrione A",Am J Physiol Cell Physiol. 2023 Aug 1;325(2):C391-C405. doi: 10.1152/ajpcell.00248.2023,Ventura E,Am J Physiol Cell Physiol,"2023, 08/01/2023",PMC10393324,10.1152/ajpcell.00248.2023,"EGFR, RYK, Wnt-5a, progranulin, tumor progression",0,"{'Elisa Ventura': ['Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States.'], 'Antonino Belfiore': ['Department of Clinical and Experimental Medicine, Endocrinology Unit, University of Catania, Garibaldi-Nesima Hospital, Catania, Italy.'], 'Renato V Iozzo': ['Department of Pathology and Genomic Medicine, and the Translational Cellular Oncology Program, Sidney Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, United States.'], 'Antonio Giordano': ['Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States.', 'Department of Biomedical Biotechnologies, University of Siena, Siena, Italy.'], 'Andrea Morrione': ['Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States.']}"
36,A paclitaxel prodrug nanoparticles with glutathion/reactive oxygen species dual-responsive and CD206 targeting to improve the anti-tumour effect,37055350,"Wang C, Jiao Y, Zhang X, Guo M, Zhang Q, Hu W, Dong S, Jakkree T, Lu Y, Wang J",IET Nanobiotechnol. 2023 Jul;17(5):406-419. doi: 10.1049/nbt2.12119,Wang C,IET Nanobiotechnol,2023,PMC10374550,10.1049/nbt2.12119,"cellular effects of radiation, drug delivery systems, drugs, nanoparticle, tumours",0,"{'Changhai Wang': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Yuwen Jiao': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Xinyu Zhang': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Mingxue Guo': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Qing Zhang': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Wenjun Hu': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Shuang Dong': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Tangthianchaichana Jakkree': ['Thammasat University, Pathum Thani, Thailand.'], 'Yang Lu': ['Department of Beijing University of Chinese Medicine, Beijing, China.'], 'Jinling Wang': ['Department of Beijing University of Chinese Medicine, Beijing, China.']}"
37,Selective targeting of lectins and their macropinocytosis in urothelial tumours: translation from in vitro to ex vivo,37535087,"Resnik N, Višnjar T, Smrkolj T, Kreft ME, Romih R, Zupančič D",Histochem Cell Biol. 2023 Aug 3. doi: 10.1007/s00418-023-02224-2,Resnik N,Histochem Cell Biol,"2023, 08/03/2023",,10.1007/s00418-023-02224-2,"Cancer urothelial cells, Endocytosis, Glycosylation, Lectins, Macropinocytosis, Urinary bladder tumours",0,"{'Nataša Resnik': ['Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.'], 'Tanja Višnjar': ['Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.'], 'Tomaž Smrkolj': ['Department of Urology, University Medical Centre Ljubljana, Ljubljana, Slovenia.', 'Department of Surgery, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.'], 'Mateja Erdani Kreft': ['Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.'], 'Rok Romih': ['Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia.'], 'Daša Zupančič': ['Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Vrazov Trg 2, 1000, Ljubljana, Slovenia. dasa.zupancic@mf.uni-lj.si.']}"
38,Molecular and Immunohistochemical Alterations in Breast Cancer Patients in Upper Egypt,37131903,"Hagag S, Kodous A, Shaaban HA",Rep Biochem Mol Biol. 2023 Jan;11(4):532-546. doi: 10.52547/rbmb.11.4.532,Hagag S,Rep Biochem Mol Biol,2023,PMC10149126,10.52547/rbmb.11.4.532,"2, Breast Cancer, Caveolin-1, ER, GATA-3, HER-2/neu, Mammaglobin, PR",0,"{'Sanaa Hagag': ['Radiation Biology department, National Center for Radiation Research & Technology, Egyptian Atomic Energy Authority, Nasr City, 8029, Cairo, Egypt.'], 'Ahmad Kodous': ['Radiation Biology department, National Center for Radiation Research & Technology, Egyptian Atomic Energy Authority, Nasr City, 8029, Cairo, Egypt.'], 'Hebat Aallh Shaaban': ['Pathology department, National Cancer Institute, Cairo University, Giza, Egypt.']}"
39,Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker,36036057,"Škara L, Vodopić T, Pezelj I, Abramovic I, Vrhovec B, Vrtarić A, Sincic N, Tomas D, Bulimbašić S, Kuliš T, Ulamec M",Biomol Biomed. 2023 Feb 1;23(1):176-186. doi: 10.17305/bjbms.2022.7497,Škara L,Biomol Biomed,"2023, 02/01/2023",PMC9901895,10.17305/bjbms.2022.7497,"High prevalence and mortality of prostate cancer (PCa) are well known global health issues Novel biomarkers for better identifying patients with PCa are the subject of extensive research Prostate specific antigen (PSA) shows low specificity in screening and diagnostics, leading to unnecessary biopsies and health costs Eighty patients with PCa and benign prostate hyperplasia (BPH) were included in the study We analyzed CAV1 gene expression and methylation in tissue CAV1 cfDNA methylation from blood and seminal plasma was accessed as a potential PCa biomarker Although methylation in blood plasma did not differ between PCa and BPH patients, methylation in seminal plasma showed better PCa biomarker performances than tPSA (AUC 063 vs AUC 052) Discrimination of BPH and Gleason grade group 1 PCa patients from patients with higher Gleason grade groups revealed very good performance as well (AUC 072) CAV1 methylation is useful biomarker with potential for further seminal plasma cfDNA research, but its diagnostic accuracy should be improved, as well as general knowledge about cfDNA in seminal plasma",0,"{'Lucija Škara': ['Department of Biology, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Group for Research on Epigenetic Biomarkers, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia.'], 'Tonći Vodopić': ['Ljudevit Jurak Clinical Department of Pathology and Cytology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'], 'Ivan Pezelj': ['Department of Urology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'], 'Irena Abramovic': ['Department of Biology, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Group for Research on Epigenetic Biomarkers, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia.'], 'Borna Vrhovec': ['Department of Urology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'], 'Alen Vrtarić': ['Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.'], 'Nino Sincic': ['Department of Biology, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Group for Research on Epigenetic Biomarkers, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia.'], 'Davor Tomas': ['Ljudevit Jurak Clinical Department of Pathology and Cytology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; Department of Pathology, University of Zagreb School of Medicine, Zagreb, Croatia.'], 'Stela Bulimbašić': ['Department of Pathology, University of Zagreb School of Medicine, Zagreb, Croatia; Pathology and Cytology Department, University Hospital Center Zagreb, Zagreb, Croatia.'], 'Tomislav Kuliš': ['Scientific Group for Research on Epigenetic Biomarkers, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia; Department of Urology, University Hospital Center Zagreb, Zagreb, Croatia.'], 'Monika Ulamec': ['Scientific Group for Research on Epigenetic Biomarkers, University of Zagreb School of Medicine, Zagreb, Croatia; Scientific Centre of Excellence for Reproductive and Regenerative Medicine, University of Zagreb School of Medicine, Zagreb, Croatia; Ljudevit Jurak Clinical Department of Pathology and Cytology, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; Department of Pathology, University of Zagreb School of Medicine, Zagreb, Croatia.']}"
40,Cardioprotective and anti-inflammatory effects of Caveolin 1 in experimental diabetic cardiomyopathy,36929208,"Gong W, Jiao Q, Yuan J, Luo H, Liu Y, Zhang Y, Chen Z, Xu X, Bai L, Zhang X",Clin Sci (Lond). 2023 Mar 31;137(6):511-525. doi: 10.1042/CS20220874,Gong W,Clin Sci (Lond),"2023, 03/31/2023",,10.1042/CS20220874,"Caveolin 1, NF-κB signaling, cardiac hypertrophy, cardiac injury, diabetic cardiomyopathy, inflammatory fibrosis",1,"{'Wenyan Gong': ['Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou 310000, China.', 'Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.'], 'Qibin Jiao': ['Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou 310000, China.'], 'Jinghua Yuan': ['Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou 310000, China.', 'Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.'], 'Hui Luo': ['Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou 310000, China.', 'Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.'], 'Yingying Liu': ['Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.', 'Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310000, China.'], 'Yuanyuan Zhang': ['Department of Cardiovascular Ultrasonic Center, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.'], 'Zhen Chen': ['Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.', 'Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310000, China.'], 'Xiaoling Xu': ['Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.', 'Key Laboratory of Aging and Cancer Biology of Zhejiang Province, School of Basic Medicine, Hangzhou Normal University, Hangzhou 311121, China.'], 'Lin Bai': ['Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medical Center, Peking Union Medical College, Beijing 100021, China.'], 'Xingwei Zhang': ['Department of Clinical Medicine, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou 310000, China.', 'Hangzhou Institute of Cardiovascular Disease, Hangzhou 310000, China.', 'Department of Cardiology, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310000, China.']}"
41,A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration,36384220,"Tang L, Zhang R, Wang Y, Zhang X, Yang Y, Zhao B, Yang L",Acta Biomater. 2023 Jan 1;155:521-537. doi: 10.1016/j.actbio.2022.11.013,Tang L,Acta Biomater,"2023, 01/01/2023",,10.1016/j.actbio.2022.11.013,"Glioma, Intranasal administration, T7-C, Tumor microenvironment, siRNA",1,"{'Lin Tang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.'], 'Rui Zhang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China. Electronic address: 526773225@qq.com.'], 'Yusi Wang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.'], 'Xiaoyu Zhang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.'], 'Yuling Yang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.'], 'Binyan Zhao': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China.'], 'Li Yang': ['State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, China. Electronic address: yl.tracy73@gmail.com.']}"
42,"Using evolutionary data to make sense of macromolecules with a ""face-lifted"" ConSurf",36718848,"Yariv B, Yariv E, Kessel A, Masrati G, Chorin AB, Martz E, Mayrose I, Pupko T, Ben-Tal N",Protein Sci. 2023 Mar;32(3):e4582. doi: 10.1002/pro.4582,Yariv B,Protein Sci,2023,PMC9942591,10.1002/pro.4582,"ConSurf, evolutionary conservation, function prediction, functional regions",13,"{'Barak Yariv': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.'], 'Elon Yariv': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.'], 'Amit Kessel': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.'], 'Gal Masrati': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.'], 'Adi Ben Chorin': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.'], 'Eric Martz': ['Department of Microbiology, University of Massachusetts, Amherst, Massachusetts, USA.'], 'Itay Mayrose': ['George S. Wise Faculty of Life Sciences, School of Plant Sciences and Food Security, Tel Aviv University, Tel Aviv, Israel.'], 'Tal Pupko': ['George S. Wise Faculty of Life Sciences, The Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv, Israel.'], 'Nir Ben-Tal': ['George S. Wise Faculty of Life Sciences, Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.']}"
43,CAVIN2/SDPR Functioned as a Tumor Suppressor in Lung Adenocarcinoma from Systematic Analysis of Caveolae-Related Genes and Experimental Validation,37497407,"Zhu K, Wang B, Li Y, Yu Y, Chen Z, Yue H, Meng Q, Tian D, Liu X, Shen W, Tian Y",J Cancer. 2023 Jul 3;14(11):2001-2014. doi: 10.7150/jca.84567,Zhu K,J Cancer,"2023, 07/03/2023",PMC10367915,10.7150/jca.84567,"LUAD, SDPR, biomarkers, cell cycle, lung cancer",0,"{'Keyun Zhu': ['Department of Thoracic Surgery, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, P. R. China, 315040.'], 'Baichuan Wang': ['Anhui Medical University Clinical College of Chest, Hefei, Anhui Province, P. R. China, 230022.', 'Anhui Chest Hospital, Hefei, Anhui Province, P. R. China, 230022.'], 'Yingxi Li': ['Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, P. R. China, 300070.'], 'Yue Yu': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Zhaohui Chen': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Haoran Yue': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Qingxiang Meng': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Dongchen Tian': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Xiaofeng Liu': [""Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, P. R. China, 300060.""], 'Weiyu Shen': ['Department of Thoracic Surgery, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, P. R. China, 315040.'], 'Yao Tian': ['Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, P. R. China, 300052.']}"
44,"Differential Expression of Caveolin-3, Suppression of Tumorigenicity 2, and Growth Differentiation Factor-15 Genes and Their Association with Acute Myocardial Infarction: A Cross-Sectional Study in a Multi-Specialty Hospital in Tamil Nadu",36989524,"Venugopal P, Logu K, Balakrishnan K, Subbaih U, Damal Kandadai S, George M",Genet Test Mol Biomarkers. 2023 Mar;27(3):109-119. doi: 10.1089/gtmb.2022.0162,Venugopal P,Genet Test Mol Biomarkers,2023,,10.1089/gtmb.2022.0162,"caveolin-3, fibrosis, markers, myocardial infarction, pathogenesis",0,"{'Priyanka Venugopal': ['Clinical Research, Hindu Mission Hospital, Chennai, India.'], 'Kannika Logu': ['Cardiology, Hindu Mission Hospital, Chennai, India.'], 'Karthikeyan Balakrishnan': ['Cardiology, Hindu Mission Hospital, Chennai, India.'], 'Usha Subbaih': ['Human Genetics Research Centre, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research (BIHER), Chennai, India.'], 'Sriram Damal Kandadai': ['Diabetology and Endocrinology, Hindu Mission Hospital, Chennai, India.'], 'Melvin George': ['Clinical Research, Hindu Mission Hospital, Chennai, India.']}"
45,Stress Activated MAP Kinases and Cyclin-Dependent Kinase 5 Mediate Nuclear Translocation of Nrf2 via Hsp90α-Pin1-Dynein Motor Transport Machinery,36829834,"Ishii T, Warabi E, Mann GE",Antioxidants (Basel). 2023 Jan 26;12(2):274. doi: 10.3390/antiox12020274,Ishii T,Antioxidants (Basel),"2023, 01/26/2023",PMC9952688,10.3390/antiox12020274,"Cdk5, ERK, HO-1, Hsp90, JNK, Nrf2, Pin1",0,"{'Tetsuro Ishii': ['School of Medicine, University of Tsukuba, Tsukuba 305-8577, Japan.'], 'Eiji Warabi': ['School of Medicine, University of Tsukuba, Tsukuba 305-8577, Japan.'], 'Giovanni E Mann': [""King's British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, 150 Stamford Street, London SE1 9NH, UK.""]}"
46,pH-Responsive and liver-targeting drug delivery system for combination delivery of artesunate with arsenic trioxide prodrug against hepatocellular carcinoma,37470495,"Pan X, Huang J, Liu S, Shao Y, Xi J, He R, Shi T, Zhuang R, Yu W",Drug Dev Ind Pharm. 2023 Aug;49(8):485-496. doi: 10.1080/03639045.2023.2239342,Pan X,Drug Dev Ind Pharm,2023,,10.1080/03639045.2023.2239342,"arsenic trioxide prodrug, artesunate, hepatocellular carcinoma, liver targeting, pH-responsive",0,"{'Xuwang Pan': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Jinsong Huang': ['Department of Hepatology, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Shourong Liu': ['Department of Hepatology, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Yidan Shao': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Jianjun Xi': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Ruoyu He': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Tingting Shi': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Rangxiao Zhuang': ['Department of Pharmaceutical Preparation, Affiliated Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.'], 'Wenying Yu': ['Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, China.']}"
47,Adipose Tissue Caveolin-1 Upregulation in Obesity Involves TNF-α/NF-κB Mediated Signaling,37048092,"Al Madhoun A, Kochumon S, Haddad D, Thomas R, Nizam R, Miranda L, Sindhu S, Bitar MS, Ahmad R, Al-Mulla F",Cells. 2023 Mar 27;12(7):1019. doi: 10.3390/cells12071019,Al Madhoun A,Cells,"2023, 03/27/2023",PMC10093236,10.3390/cells12071019,"NF-κB, TNF-α, adipose tissue, caveolin-1, cytokines, metabolic inflammation, obesity",0,"{'Ashraf Al Madhoun': ['Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.', 'Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Shihab Kochumon': ['Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Dania Haddad': ['Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Reeby Thomas': ['Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Rasheeba Nizam': ['Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Lavina Miranda': ['Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Sardar Sindhu': ['Animal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.', 'Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Milad S Bitar': ['Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.', 'Department of Pharmacology, Faculty of Medicine, Kuwait University, Jabriya 046300, Kuwait.'], 'Rasheed Ahmad': ['Immunology & Microbiology Department, Dasman Diabetes Institute, Dasman 15462, Kuwait.'], 'Fahd Al-Mulla': ['Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.']}"
48,Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice,37401372,"Huang J, Chen J",J Liposome Res. 2023 Jul 4:1-16. doi: 10.1080/08982104.2023.2228888,Huang J,J Liposome Res,"2023, 07/04/2023",,10.1080/08982104.2023.2228888,"Gist882, Hyaluronic acid, imatinib mesylate, long circulation",0,"{'Ju Huang': ['Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing, China.'], 'Jian Chen': ['Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.']}"
49,Cholesterol Is a Regulator of CAV1 Localization and Cell Migration in Oral Squamous Cell Carcinoma,37047005,"Chan NN, Yamazaki M, Maruyama S, Abé T, Haga K, Kawaharada M, Izumi K, Kobayashi T, Tanuma JI",Int J Mol Sci. 2023 Mar 23;24(7):6035. doi: 10.3390/ijms24076035,Chan NN,Int J Mol Sci,"2023, 03/23/2023",PMC10093846,10.3390/ijms24076035,"caveolin-1, cell polarization, cholesterol, migration, oral squamous cell carcinoma",0,"{'Nyein Nyein Chan': ['Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.', 'Division of Reconstructive Surgery for Oral and Maxillofacial Region, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Manabu Yamazaki': ['Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Satoshi Maruyama': ['Oral Pathology Section, Department of Surgical Pathology, Niigata University Hospital, Niigata 951-8520, Japan.'], 'Tatsuya Abé': ['Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Kenta Haga': ['Division of Reconstructive Surgery for Oral and Maxillofacial Region, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Masami Kawaharada': ['Division of Reconstructive Surgery for Oral and Maxillofacial Region, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Kenji Izumi': ['Division of Biomimetics, Department of Oral Health Science, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Tadaharu Kobayashi': ['Division of Reconstructive Surgery for Oral and Maxillofacial Region, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.'], 'Jun-Ichi Tanuma': ['Division of Oral Pathology, Department of Tissue Regeneration and Reconstruction, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8514, Japan.', 'Oral Pathology Section, Department of Surgical Pathology, Niigata University Hospital, Niigata 951-8520, Japan.']}"
50,Overexpression of Plasmalemmal Vesicle-Associated Protein-1 Reflects Glomerular Endothelial Injury in Cases of Proliferative Glomerulonephritis with Monoclonal IgG Deposits,36644361,"Sawada A, Kawanishi K, Igarashi Y, Taneda S, Hattori M, Ishida H, Tanabe K, Koike J, Honda K, Nagashima Y, Nitta K",Kidney Int Rep. 2022 Oct 19;8(1):151-163. doi: 10.1016/j.ekir.2022.10.010,Sawada A,Kidney Int Rep,"2022, 10/19/2022",PMC9831946,10.1016/j.ekir.2022.10.010,"caveolae, glomerular endothelium cells, low-vacuum scanning electron microscope (LVSEM), plasmalemmal vesicle-associated protein-1 (PV-1), proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID)",0,"{'Anri Sawada': ['Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.', ""Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan.""], 'Kunio Kawanishi': ['Department of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.'], 'Yuto Igarashi': [""Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.""], 'Sekiko Taneda': [""Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan.""], 'Motoshi Hattori': [""Department of Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan.""], 'Hideki Ishida': [""Department of Urology, Tokyo Women's Medical University, Tokyo, Japan."", ""Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan.""], 'Kazunari Tanabe': [""Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.""], 'Junki Koike': ['Department of Pathology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.'], 'Kazuho Honda': ['Department of Anatomy, Showa University School of Medicine, Tokyo, Japan.'], 'Yoji Nagashima': [""Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan.""], 'Kosaku Nitta': [""Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.""]}"
51,Caveolin-1 aggravates neurological deficits by activating neuroinflammation following experimental intracerebral hemorrhage in rats,37598879,"Cao D, Li B, Cao C, Zhang J, Li X, Li H, Yu Z, Shen H, Ye M",Exp Neurol. 2023 Oct;368:114508. doi: 10.1016/j.expneurol.2023.114508,Cao D,Exp Neurol,2023,,10.1016/j.expneurol.2023.114508,"Caveolae, Caveolin-1, Intracerebral hemorrhage, Microglia, Neuroinflammation",0,"{'Demao Cao': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China; Department of neurosurgery, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu Province, China.'], 'Bing Li': [""Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China; Department of Neurosurgery, Yancheng City No.1 People's Hospital, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng 224006, Jiangsu Province, China.""], 'Cheng Cao': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China; Department of Neurocritical Intensive Care Unit, Jiangyin Clinical College of Xuzhou Medical College, Jiangyin, Jiangsu Province, China.'], 'Juyi Zhang': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China.'], 'Xiang Li': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China.'], 'Haiying Li': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China.'], 'Zhengquan Yu': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China.'], 'Haitao Shen': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China. Electronic address: dagezi120@126.com.'], 'Ming Ye': ['Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215006, Jiangsu Province, China. Electronic address: yeming@suda.edu.com.']}"
52,Lipid droplets' functional protein caveolin-2 is associated with lipid metabolism-related molecule FABP5 and EMT marker E-cadherin in oral epithelial dysplasia,36854623,"Chen XJ, Bai YT, Xie JR, Zhou G",J Clin Pathol. 2023 Feb 28:jcp-2022-208673. doi: 10.1136/jcp-2022-208673,Chen XJ,J Clin Pathol,"2023, 02/28/2023",,10.1136/jcp-2022-208673,"E-cadherin, FABP5, caveolin-2, lipid droplets, oral potentially malignant disorders, oral squamous cell carcinoma, perilipin-3",0,"{'Xiao-Jie Chen': ['The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China.', 'Department of Oral Medicine, School and Hospital of Stomatology, Wuhan University, Wuhan, China.'], 'Yu-Ting Bai': ['The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China.'], 'Ji-Rong Xie': ['The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China.'], 'Gang Zhou': ['The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China zhougang@whu.edu.cn.', 'Department of Oral Medicine, School and Hospital of Stomatology, Wuhan University, Wuhan, China.']}"
53,Immune-Mediated Rippling Muscle Disease Associated With Thymoma and Anti-MURC/Cavin-4 Autoantibodies,36522170,"Svahn J, Coudert L, Streichenberger N, Kraut A, Gravier-Dumonceau-Mazelier A, Rotard L, Calemard-Michel L, Menassa R, Errazuriz-Cerda E, Chalabreysse L, Osseni A, Vial C, Jomir L, Tronc F, Le Duy D, Bernard E, Gache V, Couté Y, Jacquemond V, Schaeffer L, Leblanc P",Neurol Neuroimmunol Neuroinflamm. 2022 Dec 15;10(1):e200068. doi: 10.1212/NXI.0000000000200068,Svahn J,Neurol Neuroimmunol Neuroinflamm,"2022, 12/15/2022",PMC9756388,10.1212/NXI.0000000000200068,MURC/Cavin-4 autoantibodies may play a pathogenic role in paraneoplastic iRMD associated with thymoma,0,"{'Juliette Svahn': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Laurent Coudert': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Nathalie Streichenberger': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Alexandra Kraut': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Alice Gravier-Dumonceau-Mazelier': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Ludivine Rotard': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Laurence Calemard-Michel': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Rita Menassa': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Elisabeth Errazuriz-Cerda': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Lara Chalabreysse': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Alexis Osseni': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Christophe Vial': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Laurentiu Jomir': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'François Tronc': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Do Le Duy': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Emilien Bernard': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Vincent Gache': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Yohann Couté': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Vincent Jacquemond': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Laurent Schaeffer': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France.""], 'Pascal Leblanc': [""From the Electroneuromyography and Neuromuscular Department (J.S., A.G.-D.-M., C.V., L.J., E.B.), Pierre Wertheimer Hospital, Hospices Civils de Lyon; Institut NeuroMyoGène Physiopathologie et Génétique du neurone et du muscle (INMG-PGNM) (J.S., Laurent Coudert, N.S., L.R., L.C.-M., R.M., A.O., E.B., V.G., V.J., L.S., P.L.), CNRS UMR5261, INSERM U1315, Faculté de Médecine Rockefeller, Université Claude Bernard Lyon, Cedex; Department of Neuropathology (N.S., Lara Chalabreysse), Hospices Civils de Lyon; Univ. Grenoble Alpes (A.K., Y.C.), INSERM, CEA, UMR BioSanté U1292, CNRS, CEA; Department of Molecular Endocrinology and Rare Diseases (L.C.-M., R.M.), Hospices Civils de Lyon; Centre d'imagerie quantitative Lyon Est (CIQLE) (E.E.-C.), Department of Thoracic Surgery (F.T.), Hospices Civils de Lyon; Institut NeuroMyoGène INMG-MeLiS (D.L.D.), CNRS UMR5284, INSERM U1314, SynatAc Team, Faculté de Médecine Rockefeller, Universités de Lyon, Université Claude Bernard Lyon 1; and French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (D.L.D.), Hospices Civils de Lyon, France. pascal.leblanc@univ-lyon1.fr.""]}"
54,Caveolae Microdomains Mediate STAT5 Signaling Induced by Insulin in MCF-7 Breast Cancer Cells,35751654,"Castillo-Sanchez R, Cortes-Reynosa P, Lopez-Perez M, Garcia-Hernandez A, Salazar EP",J Membr Biol. 2023 Feb;256(1):79-90. doi: 10.1007/s00232-022-00253-x,Castillo-Sanchez R,J Membr Biol,2023,,10.1007/s00232-022-00253-x,"Caveolae, Insulin, STAT5",0,"{'Rocio Castillo-Sanchez': ['Departamento de Biologia Celular, Cinvestav-IPN, Av. IPN # 2508, 07360, Mexico City, Mexico.'], 'Pedro Cortes-Reynosa': ['Departamento de Biologia Celular, Cinvestav-IPN, Av. IPN # 2508, 07360, Mexico City, Mexico.'], 'Mario Lopez-Perez': ['Departamento de Biologia Celular, Cinvestav-IPN, Av. IPN # 2508, 07360, Mexico City, Mexico.'], 'Alejandra Garcia-Hernandez': ['Departamento de Biologia Celular, Cinvestav-IPN, Av. IPN # 2508, 07360, Mexico City, Mexico.'], 'Eduardo Perez Salazar': ['Departamento de Biologia Celular, Cinvestav-IPN, Av. IPN # 2508, 07360, Mexico City, Mexico. eduardo.perez@cinvestav.mx.']}"
55,Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort,37145008,"Akyildiz A, Guven DC, Yildirim HC, Ismayilov R, Yilmaz F, Tatar OD, Chalabiyev E, Kus F, Yalcin S, Aksoy S",Medicine (Baltimore). 2023 May 5;102(18):e33677. doi: 10.1097/MD.0000000000033677,Akyildiz A,Medicine (Baltimore),"2023, 05/05/2023",PMC10158859,10.1097/MD.0000000000033677,"Human epidermal growth factor receptor 2 (HER2)-targeting therapies have become crucial in the management of HER2-positive breast cancer Trastuzumab emtansine (T-DM1) is a microtubule inhibitor and HER2-targeted antibody conjugate T-DM1 resistance is most likely influenced by factors involved in the biological mechanisms of T-DM1 action This study aimed to examine the efficacy of statins, which influence HER-2-based therapies via the caveolin-1 (CAV-1) protein, in female breast cancer patients receiving T-DM1 Our study included 105 patients with HER2-positive metastatic breast cancer treated with T-DM1 The progression-free survival (PFS) and overall survival (OS) of patients who received statins concurrently with T-DM1 versus those who did not were compared During the median 395 (95% confidence interval [CI]: 356-435) months of follow-up, 16 (152%) patients received statins, and 89 (848%) patients did not Median OS was significantly higher in patients using statins than in patients not using statins (588 vs 265 months, P = 016) The association between statin use and PFS did not reach statistical significance (347 vs 99 months, P = 159) Multivariate Cox regression analysis showed that better performance status (hormone receptor [HR]: 030, 95% CI: 013-071, P = 006), use of trastuzumab plus pertuzumab prior to T-DM1 (HR: 037, 95% CI: 018-076, P = 007) and use of statins with T-DM1 (HR: 029, 95% CI: 012-070, P = 006) were independent factors that prolong OS duration Our study showed that T-DM1 is more effective at treating HER2-positive breast cancer in people who receive statins concurrently with T-DM1 than those who do not",0,"{'Arif Akyildiz': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Deniz Can Guven': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Hasan Cagri Yildirim': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Rashad Ismayilov': ['Hacettepe University Medical School, Department of Internal Medicine, Ankara, Turkey.'], 'Feride Yilmaz': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Omer Denizhan Tatar': ['Hacettepe University Medical School, Department of Internal Medicine, Ankara, Turkey.'], 'Elvin Chalabiyev': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Fatih Kus': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Suayib Yalcin': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.'], 'Sercan Aksoy': ['Hacettepe University Medical School, Department of Medical Oncology, Ankara, Turkey.']}"
56,"Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells",36839742,"Delgado A, Griera R, Llor N, López-Aguilar E, Busquets MA, Noé V, Ciudad CJ",Pharmaceutics. 2023 Jan 27;15(2):420. doi: 10.3390/pharmaceutics15020420,Delgado A,Pharmaceutics,"2023, 01/27/2023",PMC9960667,10.3390/pharmaceutics15020420,"PPRH, apoptosis, cancer, cell viability, delivery, hairpin, mammalian cell, stable transfection, therapeutic oligonucleotide, transfection agent",0,"{'Ana Delgado': ['Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.'], 'Rosa Griera': ['Department of Pharmacology, Toxicology and Therapeutic Chemistry, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.'], 'Núria Llor': ['Department of Pharmacology, Toxicology and Therapeutic Chemistry, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.'], 'Ester López-Aguilar': ['Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.'], 'Maria Antònia Busquets': ['Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.', 'Nanoscience and Nanotechnology Institute, IN2UB, University of Barcelona, 08028 Barcelona, Spain.'], 'Véronique Noé': ['Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.', 'Nanoscience and Nanotechnology Institute, IN2UB, University of Barcelona, 08028 Barcelona, Spain.'], 'Carlos J Ciudad': ['Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.', 'Nanoscience and Nanotechnology Institute, IN2UB, University of Barcelona, 08028 Barcelona, Spain.']}"
57,Cellular Uptake and Transport Mechanism of 6-Mercaptopurine Nanomedicines for Enhanced Oral Bioavailability,36636639,"Zou Y, Gao W, Jin H, Mao C, Zhang Y, Wang X, Mei D, Zhao L",Int J Nanomedicine. 2023 Jan 5;18:79-94. doi: 10.2147/IJN.S394819,Zou Y,Int J Nanomedicine,"2023, 01/05/2023",PMC9830076,10.2147/IJN.S394819,"cellular uptake, nanomedicines, oral bioavailability, transport mechanism",0,"{'Yaru Zou': [""Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China."", ""Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215025, People's Republic of China.""], 'Wei Gao': ['Department of Pharmaceutical Sciences, College of Pharmacy, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48109, USA.'], 'Huizhen Jin': [""Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215025, People's Republic of China.""], 'Chenmei Mao': [""Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, 215025, People's Republic of China.""], 'Yi Zhang': [""Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.""], 'Xiaoling Wang': [""Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.""], 'Dong Mei': [""Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China.""], 'Libo Zhao': [""Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, People's Republic of China."", ""Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, People's Republic of China.""]}"
58,"Antitumor Activity of Taxol Engross Taxol-Caveolin-1 Interaction via Lipid Raft Structure-""Caveolae""",36692650,"Bommanaboina AK, Jamal S, Ahmed N",Appl Biochem Biotechnol. 2023 Jul;195(7):4387-4398. doi: 10.1007/s12010-023-04355-7,Bommanaboina AK,Appl Biochem Biotechnol,2023,,10.1007/s12010-023-04355-7,"Beta cyclodextrin, Caveolae, Caveolin-1, TIRFM, Taxol",0,"{'Anil Kumar Bommanaboina': ['School of Life Science, B. S. Abdur Rahman Crescent Institute of Science and Technology, Tamil Nadu, 600048, Vandalur, Chennai, India.'], 'Shazia Jamal': ['School of Life Science, B. S. Abdur Rahman Crescent Institute of Science and Technology, Tamil Nadu, 600048, Vandalur, Chennai, India.'], 'Neesar Ahmed': ['School of Life Science, B. S. Abdur Rahman Crescent Institute of Science and Technology, Tamil Nadu, 600048, Vandalur, Chennai, India. neesar.sls@crescent.education.']}"
59,Customized small-sized clinostat using 3D printing and gas-permeable polydimethylsiloxane culture dish,37567883,"Kim D, Nguyen QTT, Lee S, Choi KM, Lee EJ, Park JY",NPJ Microgravity. 2023 Aug 11;9(1):63. doi: 10.1038/s41526-023-00311-1,Kim D,NPJ Microgravity,"2023, 08/11/2023",PMC10421914,10.1038/s41526-023-00311-1,"Over the past few decades, research on life in space has increased Owing to the expensive nature of and the challenges associated with conducting experiments in real space, clinostats, which continuously randomize the gravity vector by using motors, have been used to generate simulated microgravity (SMG) on Earth Herein, by using a 3D printing method, we develop a customized small-sized clinostat (CS clinostat) that is easy to manufacture, inexpensive, and robust Moreover, we develop and fabricate a gas-permeable polydimethylsiloxane culture dish that fits inside the CS clinostat To validate SMG generation, ovarian cancer cells (OV- 90, TOV-21G, and Caov-3) were applied to demonstrate a significant reduction in caveolin-1 expression, a biomarker of SMG, indicating SMG generation The proposed CS clinostat system has good accessibility for SMG research, which makes it useful as a tool for biologists, who are unfamiliar with conventional clinostat equipment, to conduct preliminary studies in the space environment",0,"{'Daehan Kim': ['Department of Mechanical Engineering, Graduate School, Chung-Ang University, Seoul, 06974, Republic of Korea.'], 'Que Thanh Thanh Nguyen': ['Department of Obstetrics and Gynecology, School of Medicine, Chung-Ang University, Seoul, 06974, Republic of Korea.'], 'Seungjin Lee': ['Department of Mechanical Engineering, Graduate School, Chung-Ang University, Seoul, 06974, Republic of Korea.'], 'Kyung-Mi Choi': ['Department of Obstetrics and Gynecology, School of Medicine, Chung-Ang University, Seoul, 06974, Republic of Korea.'], 'Eun-Ju Lee': ['Department of Obstetrics and Gynecology, School of Medicine, Chung-Ang University, Seoul, 06974, Republic of Korea. ejlee@cau.ac.kr.'], 'Joong Yull Park': ['Department of Mechanical Engineering, Graduate School, Chung-Ang University, Seoul, 06974, Republic of Korea. jrpark@cau.ac.kr.', 'Department of Intelligent Energy and Industry, Graduate School, Chung-Ang University, Seoul, 06974, Republic of Korea. jrpark@cau.ac.kr.']}"
60,"JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosis",37674628,"Cui T, Corrales-Guerrero S, Castro-Aceituno V, Nair S, Maneval DC, Monnig C, Kearney P, Ellis S, Raheja N, Raheja N, Williams TM",Mol Ther Oncolytics. 2023 Aug 18;30:181-192. doi: 10.1016/j.omto.2023.08.008,Cui T,Mol Ther Oncolytics,"2023, 08/18/2023",PMC10477748,10.1016/j.omto.2023.08.008,"Cav-1, JNTX-101, albumin, caveolin-1, gemcitabine",0,"{'Tiantian Cui': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.'], 'Sergio Corrales-Guerrero': ['Biomedical Sciences Graduate Program, The Ohio State University, Columbus, OH 43210, USA.'], 'Veronica Castro-Aceituno': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.'], 'Sindhu Nair': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.'], 'Daniel C Maneval': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Curtis Monnig': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Patrick Kearney': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Sam Ellis': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Nicholas Raheja': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Neil Raheja': ['January Therapeutics, San Diego, CA 92121, USA.'], 'Terence M Williams': ['Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010, USA.']}"
61,Red blood cell membrane-coated functionalized Au nanocage as a biomimetic platform for improved MicroRNA delivery in hepatocellular carcinoma,37178790,"Huang S, Song C, Miao J, Zhu X, Jia Y, Liu Y, Fu D, Li B, Miao M, Duan S, Zhang Z, Hu Y",Int J Pharm. 2023 Jul 25;642:123044. doi: 10.1016/j.ijpharm.2023.123044,Huang S,Int J Pharm,"2023, 07/25/2023",,10.1016/j.ijpharm.2023.123044,"Accelerated blood clearance, Au nanocage, Cellular uptake, Prolonged circulation time, Red blood cell membrane, microRNA delivery",0,"{'Shengnan Huang': ['Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province 450046, PR China; School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China.'], 'Chengzhi Song': ['Center for Quantitative Biology, Peking University, Beijing 100871, PR China.'], 'Jinxin Miao': ['Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province 450046, PR China.'], 'Xiali Zhu': ['School of Pharmaceutical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province 450046, PR China.'], 'Yongyan Jia': ['School of Pharmaceutical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province 450046, PR China.'], 'Yafei Liu': ['School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China.'], 'Dongjun Fu': ['Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, PR China.'], 'Benyi Li': ['Department of Urology, University of Kansas Medical Center, Kansas City, KS 66160, United States.'], 'Mingsan Miao': ['Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan Province 450046, PR China.'], 'Shaofeng Duan': ['School of Pharmacy, Henan University, Henan International Joint Laboratory of Chinese Medicine Efficacy, Kaifeng, Henan Province 475004, PR China. Electronic address: sduan@henu.edu.cn.'], 'Zhenzhong Zhang': ['School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China. Electronic address: zhangzhenzhong@zzu.edu.cn.'], 'Yurong Hu': ['School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, Henan Province 450001, PR China. Electronic address: huyr@zzu.edu.cn.']}"
62,Proteomic characterization of Opisthorchis felineus exosome-like vesicles and their uptake by human cholangiocytes,37225040,"Pakharukova MY, Savina E, Ponomarev DV, Gubanova NV, Zaparina O, Zakirova EG, Cheng G, Tikhonova OV, Mordvinov VA",J Proteomics. 2023 Jul 15;283-284:104927. doi: 10.1016/j.jprot.2023.104927,Pakharukova MY,J Proteomics,"2023, 07/15/2023",,10.1016/j.jprot.2023.104927,"Cell culture, Extracellular vesicles, Helminth proteomics, Opisthorchis felineus",0,"{'Maria Y Pakharukova': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia; Department of Natural Sciences, Novosibirsk State University, 2 Pirogova Str., Novosibirsk 630090, Russia. Electronic address: pmaria@yandex.ru.'], 'Ekaterina Savina': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia.'], 'Dmitry V Ponomarev': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia.'], 'Natalya V Gubanova': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia.'], 'Oxana Zaparina': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia.'], 'Elvira G Zakirova': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia; Department of Genetic Technologies, Novosibirsk State University, Novosibirsk 630090, Russia.'], 'Guofeng Cheng': [""Shanghai Tenth People's Hospital, Institute for Infectious Diseases and Vaccine Development, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200072, China.""], 'Olga V Tikhonova': ['Institute of Biomedical Chemistry, 10 Pogodinskaya Str., 119121 Moscow, Russia.'], 'Viatcheslav A Mordvinov': ['Institute of Cytology and Genetics (ICG), Siberian Branch of Russian Academy of Sciences (SB RAS), 10 Akad. Lavrentiev Ave., Novosibirsk 630090, Russia.']}"
63,Opening of Cx43-formed hemichannels mediates the Ca2+ signaling associated with endothelial cell migration,37635249,"Espinoza H, Figueroa XF",Biol Direct. 2023 Aug 28;18(1):52. doi: 10.1186/s13062-023-00408-3,Espinoza H,Biol Direct,"2023, 08/28/2023",PMC10463847,10.1186/s13062-023-00408-3,"Angiogenesis, Ca2+ signaling, Connexin hemichannels, Endothelial cells, Migration",0,"{'Hilda Espinoza': ['Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, 8330025, Chile.', 'Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad del Alba, Santiago, 8370007, Chile.'], 'Xavier F Figueroa': ['Departamento de Fisiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, 8330025, Chile. xfigueroa@bio.puc.cl.']}"
64,Bacterial RNA virus MS2 exposure increases the expression of cancer progression genes in the LNCaP prostate cancer cell line,36760518,"Sanmukh SG, Dos Santos NJ, Nascimento Barquilha C, De Carvalho M, Pintor Dos Reis P, Delella FK, Carvalho HF, Latek D, Fehér T, Felisbino SL",Oncol Lett. 2023 Jan 17;25(2):86. doi: 10.3892/ol.2023.13672,Sanmukh SG,Oncol Lett,"2023, 01/17/2023",PMC9878357,10.3892/ol.2023.13672,"MS2, androgen receptor, bacteriophage, gene expression, integrin",2,"{'Swapnil Ganesh Sanmukh': ['Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, Botucatu, São Paulo 18618-689, Brazil.', 'Synthetic and Systems Biology Unit, Biological Research Center, Eötvös Loránd Research Network, 6726 Szeged, Hungary.', 'Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland.'], 'Nilton José Dos Santos': ['Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, Botucatu, São Paulo 18618-689, Brazil.', 'Department of Structural and Functional Biology, Institute of Biology, University of Campinas, Campinas, São Paulo 13083-970, Brazil.'], 'Caroline Nascimento Barquilha': ['Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, Botucatu, São Paulo 18618-689, Brazil.', 'Department of Structural and Functional Biology, Institute of Biology, University of Campinas, Campinas, São Paulo 13083-970, Brazil.'], 'Márcio De Carvalho': ['Department of Surgery and Orthopedics, Faculty of Medicine, Sao Paulo State University, Botucatu, São Paulo 18618-687, Brazil.'], 'Patricia Pintor Dos Reis': ['Department of Surgery and Orthopedics, Faculty of Medicine, Sao Paulo State University, Botucatu, São Paulo 18618-687, Brazil.'], 'Flávia Karina Delella': ['Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, Botucatu, São Paulo 18618-689, Brazil.'], 'Hernandes F Carvalho': ['Department of Structural and Functional Biology, Institute of Biology, University of Campinas, Campinas, São Paulo 13083-970, Brazil.'], 'Dorota Latek': ['Faculty of Chemistry, University of Warsaw, 02-093 Warsaw, Poland.'], 'Tamás Fehér': ['Synthetic and Systems Biology Unit, Biological Research Center, Eötvös Loránd Research Network, 6726 Szeged, Hungary.'], 'Sérgio Luis Felisbino': ['Laboratory of Extracellular Matrix Biology, Department of Structural and Functional Biology, Institute of Biosciences of Botucatu, Sao Paulo State University, Botucatu, São Paulo 18618-689, Brazil.']}"
65,Caveolin-1 Promotes the Imbalance of Th17/Treg in Chronic Obstructive Pulmonary Disease by Regulating Hsp70 Expression,37077366,"Zhang T, Shang F, Ma Y, Xu Y, Sun W, Song H",Int J Chron Obstruct Pulmon Dis. 2023 Apr 12;18:565-574. doi: 10.2147/COPD.S398780,Zhang T,Int J Chron Obstruct Pulmon Dis,"2023, 04/12/2023",PMC10106795,10.2147/COPD.S398780,"COPD, Foxp3+ Treg cells, Hsp70, IL-17+ Th17 cells, caveolin-1",0,"{'Tongsong Zhang': [""Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong, 266042, People's Republic of China.""], 'Fangfang Shang': [""Department of Pathology, No. 971 Hospital of People's Liberation Army Navy, Qingdao, 266071, People's Republic of China.""], 'Yanhui Ma': [""Department of Clinical Laboratory, Biotherapy Center, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao, 266042, People's Republic of China.""], 'Yanxia Xu': [""Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong, 266042, People's Republic of China.""], 'Weihong Sun': [""Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong, 266042, People's Republic of China.""], 'Haiping Song': [""Department of Oncology, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong, 266042, People's Republic of China.""]}"
66,SZ168 treats LPS-induced acute lung injury by inhibiting the activation of NF-κB and MAPKs pathways,36150645,"Heng J, Wu D, Zhao Y, Lu S",Respir Physiol Neurobiol. 2023 Jan;307:103965. doi: 10.1016/j.resp.2022.103965,Heng J,Respir Physiol Neurobiol,2023,,10.1016/j.resp.2022.103965,"Acute lung injury, Inflammatory response, MH-S cells, SZ168",0,"{'Junfeng Heng': [""Intensive Care Unit, Wuxi People's Hospital, Wuxi 214023, Jiangsu, China.""], 'Dingye Wu': [""Intensive Care Unit, Wuxi People's Hospital, Wuxi 214023, Jiangsu, China.""], 'Yiming Zhao': ['Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shi-Zi Road, Suzhou 215006, Jiangsu, China. Electronic address: abwidu@163.com.'], 'Shiqi Lu': ['Department of Emergency, The First Affiliated Hospital of Soochow University, 188 Shi-Zi Road, Suzhou 215006, Jiangsu, China. Electronic address: lushiqi2004@126.com.']}"
67,Hyperglycemia Aggravates Blood-Brain Barrier Disruption Following Diffuse Axonal Injury by Increasing the Levels of Inflammatory Mediators through the PPARγ/Caveolin-1/TLR4 Pathway,35857154,"Wei X, Zhou Y, Song J, Zhao J, Huang T, Zhang M, Zhao Y",Inflammation. 2023 Feb;46(1):129-145. doi: 10.1007/s10753-022-01716-y,Wei X,Inflammation,2023,,10.1007/s10753-022-01716-y,"blood–brain barrier, diffuse axonal injury, hyperglycemia, peroxisome proliferator-activated receptor γ",0,"{'Xing Wei': [""Department of Gynaecology and Obstetrics, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.""], 'Yaqing Zhou': [""Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, 710004, People's Republic of China.""], 'Jinning Song': [""Department of Neurosurgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.""], 'Junjie Zhao': [""Department of Otorhinolaryngology Head and Neck Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.""], 'Tingqin Huang': [""Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.""], 'Ming Zhang': [""Department of Neurosurgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.""], 'Yonglin Zhao': [""Department of Oncology, the Second Affiliated Hospital of Xi'an Jiaotong University, No. 157 Xiwu Road, Xi'an, 710004, People's Republic of China. zhaoyonglinlin@163.com.""]}"
68,Downregulated CAV-1 in mouse spinal cord may alleviate bone cancer pain by inhibiting the ERK/CREB pathway,37418818,"Ge J, Song J, Sun B, Yang X, Du B, Sun X, Zhang J, Ge J, Xie H",Mutat Res. 2023 Jun 19;827:111829. doi: 10.1016/j.mrfmmm.2023.111829,Ge J,Mutat Res,"2023, 06/19/2023",,10.1016/j.mrfmmm.2023.111829,"Bone cancer pain, CAV-1, CREB, ERK1/2, Progression, Regulatory effect",0,"{'Jianyun Ge': ['Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.'], 'Jie Song': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Bo Sun': ['Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.'], 'Xuefeng Yang': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Boxiang Du': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Xin Sun': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Jiejie Zhang': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Jianlin Ge': ['Department of Anesthesiology, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu 226001, China.'], 'Hong Xie': ['Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China. Electronic address: hongx_006@163.com.']}"
69,Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs,37149114,"Silvestrini AVP, Garcia Praça F, Leite MN, de Abreu Fantini MC, Frade MAC, Badra Bentley MVL",Int J Pharm. 2023 Jun 10;640:123019. doi: 10.1016/j.ijpharm.2023.123019,Silvestrini AVP,Int J Pharm,"2023, 06/10/2023",,10.1016/j.ijpharm.2023.123019,"Liquid crystalline nanoparticle, Psoriasis, Skin delivery, Small interfering RNA, Triptolide",1,"{'Ana Vitória Pupo Silvestrini': ['School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, 14040-903, Ribeirao Preto, SP, Brazil.'], 'Fabíola Garcia Praça': ['School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, 14040-903, Ribeirao Preto, SP, Brazil.'], 'Marcel Nani Leite': ['Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Institute of Physics, University of Sao Paulo, 05508-900, São Paulo, SP, Brazil.'], 'Márcia Carvalho de Abreu Fantini': ['Institute of Physics, University of Sao Paulo, 05508-900, São Paulo, SP, Brazil.'], 'Marco Andrey Cipriani Frade': ['Division of Dermatology, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil; Institute of Physics, University of Sao Paulo, 05508-900, São Paulo, SP, Brazil.'], 'Maria Vitória Lopes Badra Bentley': ['School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, 14040-903, Ribeirao Preto, SP, Brazil. Electronic address: vbentley@usp.br.']}"
70,"Inhibition of cholesterol transport impairs Cav-1 trafficking and small extracellular vesicles secretion, promoting amphisome formation in melanoma cells",36519961,"Peruzzu D, Boussadia Z, Fratini F, Spadaro F, Bertuccini L, Sanchez M, Carollo M, Matarrese P, Falchi M, Iosi F, Raggi C, Parolini I, Carè A, Sargiacomo M, Gagliardi MC, Fecchi K",Traffic. 2023 Feb;24(2):76-94. doi: 10.1111/tra.12878,Peruzzu D,Traffic,2023,,10.1111/tra.12878,"amphisomes, autophagy, caveolin, cell migration, cholesterol, endosome, extracellular vesicles, melanoma",0,"{'Daniela Peruzzu': ['Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Zaira Boussadia': ['National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy.'], 'Federica Fratini': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Francesca Spadaro': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Lucia Bertuccini': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Massimo Sanchez': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Maria Carollo': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Paola Matarrese': ['Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Mario Falchi': ['National Center for HIV/AIDS Research, Istituto Superiore di Sanità, Rome.'], 'Francesca Iosi': ['Core Facilities Technical Scientific Service, Istituto Superiore di Sanità, Rome, Italy.'], 'Carla Raggi': ['National Center for the control and evaluation of Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Isabella Parolini': ['Department Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Alessandra Carè': ['Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Massimo Sargiacomo': ['National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.'], 'Maria Cristina Gagliardi': ['Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.'], 'Katia Fecchi': ['Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.']}"
71,EPIC-1042 as a potent PTRF/Cavin1-Caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for Glioblastoma,37651725,"Hong B, Yang E, Su D, Ju J, Cui X, Wang Q, Tong F, Zhao J, Yang S, Cheng C, Xin L, Xiao M, Yi K, Zhan Q, Ding Y, Xu H, Cui L, Kang C",Neuro Oncol. 2023 Aug 31:noad159. doi: 10.1093/neuonc/noad159,Hong B,Neuro Oncol,"2023, 08/31/2023",,10.1093/neuonc/noad159,"Autophagy, PARP1, Small-Molecular Inhibitor, TMZ efficacy, TMZ efflux",0,"{'Biao Hong': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Eryan Yang': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Dongyuan Su': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Jiasheng Ju': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Xiaoteng Cui': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Qixue Wang': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Fei Tong': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Jixing Zhao': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Shixue Yang': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Chunchao Cheng': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Lei Xin': ['Department of Neurosurgery, Affiliated Hospital of Hebei University, Baoding 071000, China.'], 'Menglin Xiao': ['Department of Neurosurgery, Affiliated Hospital of Hebei University, Baoding 071000, China.'], 'Kaikai Yi': [""Department of Neuro-Oncology and Neurosurgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin, China.""], 'Qi Zhan': ['Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin, China.'], 'Yaqing Ding': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Hanyi Xu': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Longtao Cui': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.'], 'Chunsheng Kang': ['Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-oncology, Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.']}"
72,Fowl adenovirus serotype 4 enters leghorn male hepatocellular cells via the clathrin-mediated endocytosis pathway,36918926,"Wang T, Wang L, Li W, Hou X, Chang W, Wen B, Han S, Chen Y, Qi X, Wang J",Vet Res. 2023 Mar 14;54(1):24. doi: 10.1186/s13567-023-01155-z,Wang T,Vet Res,"2023, 03/14/2023",PMC10015710,10.1186/s13567-023-01155-z,"FAdV-4, LMH cells, clathrin, endocytosis, entry",0,"{'Ting Wang': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Lizhen Wang': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Wei Li': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Xiaolan Hou': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Wenchi Chang': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Bo Wen': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Shuizhong Han': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Yan Chen': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China.'], 'Xuefeng Qi': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China. yxyan2002@163.com.'], 'Jingyu Wang': ['College of Veterinary Medicine, Northwest A&F University, 712100, Yangling, Shaanxi, China. wjingyu2004@126.com.']}"
73,Structural analysis of the P132L disease mutation in caveolin-1 reveals its role in the assembly of oligomeric complexes,36870682,"Han B, Gulsevin A, Connolly S, Wang T, Meyer B, Porta J, Tiwari A, Deng A, Chang L, Peskova Y, Mchaourab HS, Karakas E, Ohi MD, Meiler J, Kenworthy AK",J Biol Chem. 2023 Apr;299(4):104574. doi: 10.1016/j.jbc.2023.104574,Han B,J Biol Chem,2023,PMC10124911,10.1016/j.jbc.2023.104574,"cancer, caveolae, caveolin, computational biology, intracellular trafficking, membrane protein, oligomerization, structural biology",0,"{'Bing Han': ['Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA; Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.'], 'Alican Gulsevin': ['Department of Chemistry, Vanderbilt University, Nashville, TN, USA.'], 'Sarah Connolly': ['Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.'], 'Ting Wang': ['Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA; Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.'], 'Brigitte Meyer': ['Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.'], 'Jason Porta': ['Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.'], 'Ajit Tiwari': ['Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA; Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.'], 'Angie Deng': ['Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.'], 'Louise Chang': ['Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.'], 'Yelena Peskova': ['Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA; Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA.'], 'Hassane S Mchaourab': ['Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.'], 'Erkan Karakas': ['Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.'], 'Melanie D Ohi': ['Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, University of Michigan School of Medicine, Ann Arbor, MI, USA.'], 'Jens Meiler': ['Department of Chemistry, Vanderbilt University, Nashville, TN, USA; Institute for Drug Discovery, Leipzig University, Leipzig, Germany.'], 'Anne K Kenworthy': ['Center for Membrane and Cell Physiology, University of Virginia, Charlottesville, VA, USA; Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: Akk7hp@virginia.edu.']}"
74,Oscillating Glucose Induces the Increase in Inflammatory Stress through Ninjurin-1 Up-Regulation and Stimulation of Transport Proteins in Human Endothelial Cells,37189375,"Toma L, Sanda GM, Stancu CS, Niculescu LS, Raileanu M, Sima AV",Biomolecules. 2023 Mar 30;13(4):626. doi: 10.3390/biom13040626,Toma L,Biomolecules,"2023, 03/30/2023",PMC10135653,10.3390/biom13040626,"Ninjurin-1, endothelial cell dysfunction, inflammatory stress, oscillating glucose, oxidative stress, transendothelial transport proteins",0,"{'Laura Toma': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.'], 'Gabriela M Sanda': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.'], 'Camelia S Stancu': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.'], 'Loredan S Niculescu': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.'], 'Mina Raileanu': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.'], 'Anca V Sima': ['Lipidomics Department, Institute of Cellular Biology and Pathology ""Nicolae Simionescu"" of the Romanian Academy, 8, B.P. Hasdeu Street, 050568 Bucharest, Romania.']}"
75,Silencing information regulator 1 ameliorates lipopolysaccharide-induced acute lung injury in rats via the upregulation of caveolin-1,37336147,"Tong F, Shen W, Zhao J, Hu Y, Zhao Q, Lv H, Liu F, Meng Z, Liu J",Biomed Pharmacother. 2023 Sep;165:115018. doi: 10.1016/j.biopha.2023.115018,Tong F,Biomed Pharmacother,2023,,10.1016/j.biopha.2023.115018,"Acute lung injury, Caveolin-1, Signal transducer and activator of transcription 3, Silencing information regulator 1, lipopolysaccharide",0,"{'Fei Tong': ['Department of Anaesthesiology, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, No.1558 Sanhuan North Road, Huzhou City, Zhejiang Province, China.'], 'Wenchao Shen': ['Department of Radiology, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, No.315, South Street, Wuxing District, Huzhou City, Zhejiang Province, China.'], 'Jingjing Zhao': ['Department of Hospital-acquired Infection Control, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, No.1558 Sanhuan North Road, Huzhou City, Zhejiang Province, China.'], 'Yonghe Hu': ['Department of Anaesthesiology, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, No.1558 Sanhuan North Road, Huzhou City, Zhejiang Province, China.'], 'Qi Zhao': ['Department of Anaesthesiology, Huzhou Fourth Hospital, No.169 Chengnan Road, Wuxing District, Huzhou City, Zhejiang Province, China.'], 'Huizhi Lv': [""Department of Anaesthesiology, Taizhou Sanmen County People's Hospital, No.15 Taihe Road, Hairun Street, Sanmen County, Zhejiang Province, China.""], 'Feifan Liu': ['Department of Anaesthesiology, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, No.1558 Sanhuan North Road, Huzhou City, Zhejiang Province, China. Electronic address: 690130223@qq.com.'], 'Zhipeng Meng': ['Department of Anaesthesiology, Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Affiliated Central Hospital of Huzhou University, No.1558 Sanhuan North Road, Huzhou City, Zhejiang Province, China. Electronic address: mengzp@zjhz.edu.cn.'], 'Jing Liu': ['Department of Anaesthesiology, Huzhou Maternity & Child Health Care Hospital,WuXing Area NO.2 East Street, Huzhou City,Zhejiang Province, China. Electronic address: 849796799@qq.com.']}"
76,Liang-Ge-San inhibits dengue virus serotype 2 infection by reducing caveolin1-induced cytoplasmic heat shock protein 70 translocation into the plasma membrane,37506573,"Chen X, Yang JB, Cao HH, Fang XC, Liu SH, Zou LF, Yu JH, Zuo JP, Zhao W, Lu ZB, Liu JS, Yu LZ",Phytomedicine. 2023 Oct;119:154977. doi: 10.1016/j.phymed.2023.154977,Chen X,Phytomedicine,2023,,10.1016/j.phymed.2023.154977,"Caveolin1, Dengue virus serotype 2, Envelope protein, Heat shock protein 70, Liang-Ge-San",0,"{'Xi Chen': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Jia-Bin Yang': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Hui-Hui Cao': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Xiao-Chuan Fang': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Shan-Hong Liu': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Li-Fang Zou': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China.'], 'Jian-Hai Yu': ['Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, 510515, PR China.'], 'Jian-Ping Zuo': ['Laboratory of Immunopharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.'], 'Wei Zhao': ['Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, 510515, PR China.'], 'Zi-Bin Lu': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China. Electronic address: huang624@smu.edu.cn.'], 'Jun-Shan Liu': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, China, 510280, PR China. Electronic address: liujunshan@smu.edu.cn.'], 'Lin-Zhong Yu': ['Third Level Research Laboratory of State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China. Electronic address: yulzh@smu.edu.cn.']}"
77,"Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels",37419919,"Peche VS, Pietka TA, Jacome-Sosa M, Samovski D, Palacios H, Chatterjee-Basu G, Dudley AC, Beatty W, Meyer GA, Goldberg IJ, Abumrad NA",Nat Commun. 2023 Jul 7;14(1):4029. doi: 10.1038/s41467-023-39752-3,Peche VS,Nat Commun,"2023, 07/07/2023",PMC10329018,10.1038/s41467-023-39752-3,"Endothelial cell (EC) CD36 controls tissue fatty acid (FA) uptake Here we examine how ECs transfer FAs FA interaction with apical membrane CD36 induces Src phosphorylation of caveolin-1 tyrosine-14 (Cav-1Y14) and ceramide generation in caveolae Ensuing fission of caveolae yields vesicles containing FAs, CD36 and ceramide that are secreted basolaterally as small (80-100 nm) exosome-like extracellular vesicles (sEVs) We visualize in transwells EC transfer of FAs in sEVs to underlying myotubes In mice with EC-expression of the exosome marker emeraldGFP-CD63, muscle fibers accumulate circulating FAs in emGFP-labeled puncta The FA-sEV pathway is mapped through its suppression by CD36 depletion, blocking actin-remodeling, Src inhibition, Cav-1Y14 mutation, and neutral sphingomyelinase 2 inhibition Suppression of sEV formation in mice reduces muscle FA uptake, raises circulating FAs, which remain in blood vessels, and lowers glucose, mimicking prominent Cd36-/- mice phenotypes The findings show that FA uptake influences membrane ceramide, endocytosis, and EC communication with parenchymal cells",0,"{'V S Peche': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA. pechev@wustl.edu.'], 'T A Pietka': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'M Jacome-Sosa': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'D Samovski': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'H Palacios': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'G Chatterjee-Basu': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'A C Dudley': ['Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, 22908, USA.'], 'W Beatty': ['Department of Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.'], 'G A Meyer': ['Departments of Physical Therapy, Neurology and Orthopedic Surgery, Washington University School of Medicine, St. Louis, 63110, USA.'], 'I J Goldberg': ['Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, New York University Grossman School of Medicine, New York, NY, 10016, USA.'], 'N A Abumrad': ['Department of Medicine, Division of Nutritional Sciences, Washington University School of Medicine, St. Louis, MO, 63110, USA. nabumrad@wustl.edu.', 'Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, 63110, USA. nabumrad@wustl.edu.']}"
78,"Negatively charged Cu1.33S nanochains: endocytic pathway, photothermal therapy and toxic effect in vivo",36926579,"Luo L, Wang Z",Nanoscale Adv. 2023 Jan 27;5(6):1706-1713. doi: 10.1039/d2na00776b,Luo L,Nanoscale Adv,"2023, 01/27/2023",PMC10012857,10.1039/d2na00776b,"Negatively charged nanomaterials have good biocompatibility and low cytotoxicity, but the efficiency of their entry into cells is relatively low Thus, striking a balance between cell transport efficiency and cytotoxicity is a challenging problem in the field of nanomedicine In this work, negatively charged Cu133S nanochains have shown a higher cellular uptake level in 4T1 cells than Cu133S nanoparticles with a similar diameter and surface charge Inhibition experiments indicate that the cellular uptake of the nanochains depends principally on the lipid-raft protein (ie caveolin-1) mediated pathway, although the role of clathrin cannot be ruled out Caveolin-1 can provide short-range attraction at the membrane interface Furthermore, by using biochemical analysis, blood routine examination and histological evaluation on healthy Sprague Dawley rats, it is found that the Cu133S nanochains have no obvious toxic effect The Cu133S nanochains have an effective photothermal therapy effect of tumor ablation in vivo under low injection dosage and laser intensity As for the best performing group (20 μg + 1 W cm-2), the temperature of the tumor site rapidly increases within the initial 3 min and rises to a plateau of 79 °C (ΔT = 46 °C) at 5 min These results reveal the feasibility of the Cu133S nanochains as a photothermal agent",0,"{'Le Luo': [""Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University Wuhu 241000 People's Republic of China zhwang@ahnu.edu.cn.""], 'Zhenghua Wang': [""Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University Wuhu 241000 People's Republic of China zhwang@ahnu.edu.cn.""]}"
